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Abstract 
 
The Helicoverpa armigera stunt virus (HaSV) is a member of a family of small non-
enveloped (+) ssRNA insect viruses currently known as the Tetraviridae.  This family 
is unique in terms of the T=4 quasi-symmetry of its capsid particles and the 
unusually narrow host range and tissue tropism.  Assembly of tetraviral particles has 
been well characterised and involves the combination of 240 copies of a single 
capsid precursor protein (VCap) into a procapsid followed by autoproteolytic 
cleavage to yield the major (β) and minor (γ) capsid subunits within the mature 
particle.  HaSV has two genomic RNAs, RNA 1 encoding the replicase and RNA 2 
encoding VCap and p17, the ORF of which lies upstream of and overlaping with the 
5’ end of the VCap ORF.  Prior to this study, Vlok (2009) used a plasmid expression 
system to study RNA packaging in HaSV VLPs assembled in Spodoptera frugiperda 
9 (Sf9) cells co-expressing p17 and VCap.  The study showed that the p17 ORF was 
required for the packaging of RNA 2 during capsid assembly but it was unclear 
whether p17 expression was required for packaging.  In addition, expression from 
the transfected plasmids was sub-optimal affecting both the yield of VLPs and the 
detection of p17.  The aim of this study was to use the plasmid system to test 
whether p17 expression was required for plasmid-derived VLP RNA packaging and 
then develop a baculovirus-mediated system to test this hypothesis. 
 
By using a plasmid in which the start codon of p17 was mutated, it was shown that 
p17 expression was required for RNA 2 packaging into plasmid-VLPs.  For the 
baculovirus system, four recombinant baculoviruses based upon the pFastBac Dual 
expression system, were constructed.  These included Bac20, expressing wild type 
RNA 2, Bac21, RNA 2 with p17 silenced, Bac23, RNA 2 and p17 expressed on a 
separate transcript and Bac24, RNA 2 with p17 silenced plus p17 expressed on a 
separate transcript.  Assembly of VLPs was more efficient using the baculovirus 
expression system and p17 expression was observed in cells infected with Bac20, 
Bac23 and Bac24, but not Bac21.  In contrast to the plasmid-VLPs, bac-VLPs did not 
require p17 for the encapsidation of RNA 2.  In addition to RNA 2, Bac23 and Bac24 
packaged the p17 mRNA transcribed separately from RNA 2.  This insinuated that 
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bac-VLPs may be packaging RNA non-selectively.  It was proposed that p17 may 
play a role in packaging in an RNA-limiting environment (plasmid system) but 
functioned differently when viral RNA was in excess (baculovirus system).  This data 
points to the importance of developing a replication system for the analysis of the 
packaging pathways of these viruses and this study has laid down the foundations 
for such a system in which RNA 1 and RNA 2 can be introduced into a single cell by 
means of a single recombinant virus. 
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Chapter 1 
Literature review 
 
1.1 Introduction 
In the classical definition of the infectious life cycle, a virus must attach to and enter 
the host cell, express its genes and set up replication factories, replicate the viral 
genome, assemble new virus progeny and then release the progeny to infect the 
next cell.  Unfortunately for the cell but fortunately for the virus, there are virtually an 
unlimited number of ways in which these steps may be modified to infect any cell 
type on the planet, but in general this definition represents a handy framework within 
which to compare the life cycles of seemingly unrelated viruses.   
 
Since the 1970s, virus assembly has been an extensively studied area of the viral life 
cycle, due in part to availability of the technology of the time, i.e. X-ray 
crystallography and electron microscopy (Rossmann and Johnson, 1989).  
According to a review on virus assembly by Casjens and King in 1975, assembly of a 
virus particle involves the following basic steps: (1) protein subunits coming together 
to form a closed shell, (2) the packaging of nucleic acids into this shell, (3) any other 
steps required to make the newly formed particle infectious and (4) the regulation of 
both the structure and information encoded by these particles by various processes.  
In addition, the authors motivated for the study of virus assembly by maintaining that 
effective anti-viral therapy could only be achieved when factors influencing assembly 
were well understood (Casjens and King, 1975).  Although this is a rather dated 
review, the reasons behind the analysis of viral assembly mechanisms are still as 
important today as they were more than 30 years ago.  
 
Icosahedral viruses have always been at the forefront of the study of assembly 
pathways.  Indeed Rossmann and Johnson (1989), stated that the elucidation of the 
structure of Tomato Bushy stunt virus (Harrison et al., 1978) and Tobacco mosaic 
virus (TMV), (Bloomer et al., 1978) themselves icosahedral single-stranded (ss)RNA 
viruses, “initiated high-resolution structural virology”.  The structure of plant viruses 
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was studied by Crick and Watson as early as 1956, in a paper in which they 
elegantly outlined how regular polyhedrons may be an accurate representation of the 
shape of virus particles (Crick and Watson, 1956).  They proposed that the small 
amount of information encoded on a viral nucleic acid would be sufficient for a 
protein which had a molecular weight of only a fraction of the whole capsid.  Multiple 
copies of this protein would thus have to be repeated in order to fully encapsulate the 
nucleic acid without any gaps and thus only a regular polyhedron shape could 
realistically adhere to these conditions (Crick and Watson, 1956).   
 
In 1962 Casper and Klug advanced the theory developed by Crick and Watson, by 
showing that in order for one protein to produce a regular polyhedron, each of its 
copies had to take up a “quasi-equivalent” environment in relation to its neighbour.  
An icosahedron of quasi-equivalent proteins was predicted as the most favourable 
polyhedron and this has proven accurate given the number of icosahedral viruses 
isolated to date (Natarajan et al., 2005).  Furthermore Casper and Klug noted that 
when more than one protein makes up each face of an icosahedral virus, a 
triangulation number (T) should be used to identify the number of quasi-equivalent 
units, therefore, making 60T the number of proteins making up an icosahedral capsid 
particle.  During these studies, another important element of virus assembly came to 
light in the realisation that in order to assemble a capsid, several different types of 
non-equivalent contacts are needed to complete the shell (Harrison, 2001).  This 
means identical subunits need to make non-identical contacts in a quasi-symmetrical 
icosahedral structure and somehow the virus needs to make a choice as to which 
contacts to make and when in order to achieve the most optimal arrangement 
(Harrison, 2001).  The accurate assembly of these contacts as well as the 
incorporation of the genome within represent the major challenges that have 
moulded the specificity with which viruses assemble icosahedral particles.      
 
1.2 Assembly of icosahedral viruses 
The mechanism of assembly of a virus is determined by its capsid proteins and in 
the past the major emphasis has been on determining how a similar set of these 
proteins is able to arrange a symmetrical icosahedral structure (Schneemann, 2006).  
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In fact, the protein-protein interactions are but one third of the process of assembling 
viruses.  According to Fox et al. (1994) both sequence specific RNA-protein 
interactions (generally responsible for initiation and regulation of assembly) and 
sequence independent RNA-protein interactions (responsible for stabilizing 
packaged RNA), must take place before the formation of a capsid shell around RNA 
viruses.  In addition, the ability of the virus to select and package only viral RNA from 
the slew of cellular RNA is essential for efficient assembly.  A review of some of the 
basic systems available for the study of the assembly of icosahedral viruses is 
presented in Table 1.1.  High resolution protein structural data was extremely useful 
in these systems and traditionally in vitro assembly experiments were favoured.  Due 
to the limitations of molecular techniques in the past, the protein-nucleic acid 
interactions have only recently become the focus of attention and there is now 
increasing structural data relating to how these two molecules combine to form 
viruses (Schneemann, 2006).  There is however, still limited information on how the 
RNA is specifically packaged into icosahedral virus particles and there are even 
fewer studies that have delved into the specific intracellular events involved.   
         
Table 1.1: Model systems available for the study of icosahedral RNA virus 
assembly 
Virus  RNA genome 
Capsid 
proteins 
In vitro 
assembly 
system 
Identification 
of packaging 
signal 
High 
resolution 
structure 
Plant 
Cowpea 
chlorotic mottle 
virus 
Multiple Single Yes No Yes 
Turnip crinkle 
virus Single Single Yes Yes Yes 
Bacteria 
Phage R17 Single Single Yes Yes No 
Animal 
Hepatitis B 
pregenome 
Single Single No Yes No 
Sindbis virus Single Single Yes Yes No 
(Adapted from Fox et al., 1994) 
 
Icosahedral ssRNA viruses have been organised into three categories based upon 
the similarity of their capsid structure and assembly mechanisms.  The first category 
is the ssRNA plant viruses.  These viruses tend to exhibit the traditional T=1 or T=3 
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capsid symmetry, with the only exception being the Comovirus group that is more 
similar to the picornaviruses (Casjens and King, 1975; Chen et al., 1989). The 
positive sense (+) ssRNA bacteriophages represent the second structural group as 
these viruses package their RNA plus an A protein into distinctive icosahedral head 
structures with varying symmetries (Hohn and Hohn, 1970).  Perhaps the best 
studied in terms of structure and molecular biology is the third group, the animal 
picornaviruses (Wien et al., 1996).  These viruses have been shown to exhibit a 
pseudo-T=3 capsid symmetry or P=3, as each protein in the asymmetric unit does 
not have the same amino acid sequence but still takes up a quasi-equivalent 
environment in the capsid particle (Rossmann and Johnson, 1989).  A diagrammatic 
representation of the comparison between the T symmetry of the plant viruses 
versus the P symmetry of the picorna and comoviruses is presented in Fig. 1.1.    
 
 
 
Figure 1.1: Structure of icosahedral RNA viruses.  The majority of plant and 
insect viruses are represented in the top tier as their capsid structures tend to exhibit 
T=3 or T=1 symmetry.  T=1 viruses contain only one capsid protein (A) per 
asymmetric capsid face, while T=3 viruses require three of the same proteins (A, B 
and C) each in a quasi-equivalent environment.  The picornaviruses and the plant 
group, the comoviruses, are represented in the bottom tier.  The symmetry in this 
instance is described as P=3, as the proteins are quasi-equivalent but VP1, 2 and 3 
are not the same protein.  Comoviruses combine two large subunit proteins (L) and a 
small subunit protein (s) to resemble the P=3 symmetry (Taken from Rossmann and 
Johnson, 1989). 
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1.3 RNA packaging 
The mechanisms by which all the viruses in the above mentioned groups assemble 
both the protein and RNA components together have been generalised into two 
basic pathways.  The first is called the procapsid pathway, in which there is the initial 
assembly of a procapsid (partially assembled capsid particle) into which the RNA is 
inserted.  The second insinuates a greater responsibility on the RNA and involves 
viral RNA-protein complexes being formed, which then initiate the assembly of 
additional protein components around the RNA to form a closed shell (Fox et al., 
1994).  Although by no means a rule, many phages and picornaviruses utilise the 
procapsid pathway while many plant viruses make ribonucleoprotein complexes (Fox 
et al., 1994).  These pathways provide a basis behind what is known as packaging. 
 
Packaging refers to the point in the assembly process when nucleic acids are to be 
incorporated into the capsid and in general, it is largely the responsibility of the 
capsid protein to identify specific signals on viral RNA and carry out this process 
(Liljas, 1999).  The capsid proteins of many icosahedral RNA viruses surprisingly 
share a major similarity in that the shell forming unit of these viruses is essentially 
the same eight antiparallel β-strands in a “jelly roll” formation (Rossmann and 
Johnson, 1989).  There are a variety of ways that domains have been inserted 
between and around the β-strands of the jelly-roll core, but RNA viruses all tend to 
incorporate largely positively charged N or C-terminal residues on the interior face of 
the capsid in order to bind negatively charged RNA (Schneemann, 2006).  Although 
the structure of the RNA within the capsid is becoming clearer, the mechanisms by 
which capsid proteins identify viral RNA as opposed to cellular RNAs are not as well 
understood and a variety of factors have been shown to play a role.  
 
RNA secondary structure is generally an important element for recognition by capsid 
proteins.  For example the Hepatitis B virus (Hepnaviridae) utilises a stem-and-loop 
region known as the ε site as a packaging signal for pregenomic RNA to be 
packaged into the nucleocapsid core (Kramvis and Kew, 1998).  Despite differing 
primary sequences, it has been predicted that all hepanaviruses not only require this 
structure for selectively packaging subgenomic RNA, but also for the activation of 
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reverse transcription (Fallows and Goff, 1995).  A general feature of RNA packaging 
is that it is difficult to differentiate the requirements for packaging from other viral 
processes that may be tightly coupled to packaging, such as reverse transcription (in 
hepnaviruses) and replication (linked in nodaviruses and bromoviruses) (Fallows and 
Goff, 1995; Venter and Schneemann, 2007).  Other examples of RNA viruses that 
utilise stem-and-loop packaging signals are the togavirus, Sindbis virus and the 
coronavirus, Mouse hepatitis virus (Frolova et al., 1997; Molenkamp and Spaan, 
1997).  Whether these signals play a role in other processes within the lifecycle of 
these viruses is yet to be determined.  
 
A 
 
B 
 
 
Figure 1.2: Structure of the HIV nucleocapsid protein (NC) and the CCMV 
capsid protein.  (A)  Ball and stick model of the HIV-1 NC protein, showing the two 
zinc-knuckle domains bound to zinc atoms (cyan) towards the middle of the protein 
(backbone – grey, Cys – yellow, His – blue, flexible tail – red) (D’Souza and 
Summers, 2005).  (B)  Ribbon diagram of the CCMV coat protein (β sheets – red 
and α helices – green).  The N terminal region prior to the first β sheet contains an 
ARM which is critical in RNA recognition (Taken from Speir et al., 2006). 
 
Viral RNA is recognised by many common motifs found on the capsid proteins of 
unrelated viruses and therefore, the capsid protein itself is another important element 
in RNA packaging although, many capsid proteins have been observed to lack a 
specific RNA binding motif and still bind RNA.  This is probably due to the fact that 
with the structural diversity of RNA comes a large degree of diversity in the way 
proteins can bind to it (Draper, 1995).  The arginine-rich motif (ARM) is an example 
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of a widely used RNA recognition motif (Fig. 1.2 B).  It is used by the capsid protein 
of the nodavirus Flock House virus (FHV) to package RNA 1 (Venter et al., 2009), 
the capsid proteins of members of the Bromovirus genus, Brome mosaic virus (BMV) 
and Cowpea chloritic mottle virus (CCMV) to package their RNAs (Annamalai et al., 
2005) and by the Human Immunodeficiency virus (HIV) REV and TAT proteins for 
their separate functions in regulating HIV gene expression (Draper, D. 1995).  Zinc-
finger or zinc-knuckle domains are another example of RNA binding domains (Fig. 
1.2 A).  The HIV nucleocapsid protein (NC) domain of the GAG polyprotein contains 
one or two such zinc-fingers that aid in the selective packaging of the RNA dimer into 
the nucleoprotein core (D’Souza and Summers, 2005). 
 
Other factors over and above protein-RNA interactions can play equally important 
roles in RNA packaging.  Both the RNA and the capsid protein may need to be in 
close proximity in order to facilitate binding and this makes the site of assembly 
another key consideration.  An example of this comes from the nodaviruses, where it 
has been shown that targeting to the mitochondria may represent a key process in 
the sequential packaging of RNA 1 and RNA 2 (Venter et al., 2009).  Cellular 
proteins can also be involved in RNA packaging, an example of which is the heat 
shock protein 90 (Hsp90).  Hsp90 is involved in binding to the ε site of Hepatitis B 
virus and could have some effect on the packaging of both the polymerase and the 
RNA into the nucleocapsid (Kramvis and Kew, 1998). 
 
In summary, packaging and assembly of icosahedral RNA viruses involves a variety 
of viral and cellular elements combining to make an infectious particle.  In the past, 
there has been a trend to separate these into separate bodies of work, involving 
either packaging or assembly pathways.  In reality these pathways are heavily 
interlinked and very often it is the interaction of protein and RNA that simultaneously 
initiates assembly and packaging in the first place.   
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1.4 Tetraviruses 
The family of interest in this study is the Tetraviridae, a family of viruses that infect 
exclusively insect hosts and thus the question arose as to where insect viruses fitted 
in, in terms of their strategies for assembly and packaging.  In 1998 Christian and 
Scotti categorised the RNA viruses that infect insects into four key families: the 
Picornaviridae, Dicistroviridae, Nodaviridae and Tetraviridae.  When one examines 
these families closely it would seem that the insect picornaviruses assimilate into the 
P=3 picornavirus assembly group (Knowles et al., 2011).  On the other hand, the 
dicistroviruses (which have a T=3 symmetry despite formally being part of the family 
Picornaviridae), the nodaviruses (T=3) and tetraviruses (T=4) bear the most 
similarity to the first assembly category, the ssRNA plant viruses, based on their 
capsid symmetry and varying degrees of similarity in genome organisation as well 
(Chen et al., 2011; Thiéry et al., 2011; Dorrington et al., 2011).  This literature review 
will focus on the specific packaging and assembly of (+) ssRNA into the first 
assembly category, the ssRNA plant viruses and by extension the insect viruses.  
The review will highlight what is known about assembly and packaging of the 
Bromoviridae, a family of T=3 plant viruses, continue through the Nodaviridae, a 
family of T=3 insect viruses ending off with what little is known about tetravirus 
packaging, in the hope that by contrasting structurally similar viruses, some clues will 
be will discovered as to which of the packaging factors are important in the 
Tetraviridae. 
 
The tetraviruses are a relatively underexplored family of non-enveloped insect (+) 
ssRNA viruses.  It is surprising that so little research has been done on this family 
given the peculiar properties of these viruses.  Tetraviruses were the first T=4 
icosahedral viruses to be discovered and it is for this reason that the family has been 
named the Tetraviridae (Finch et al., 1974).  Tetravirus particles are relatively small, 
ranging from 32 – 42 nm in diameter (Dorrington et al., 2011).  Both the host range 
and tissue tropism of these viruses is very narrow, to date they have only been found 
to infect the larvae of moths and butterflies belonging to the order Lepidoptera and 
can only be isolated from the midgut tissue of their host species (Finch et al., 1974; 
Dorrington et al., 2011; Brooks et al., 2002).  In addition, only one tetravirus species, 
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Providence virus (PrV), has been shown to replicate in tissue cultured cells despite 
numerous attempts with various cell lines (Pringle et al., 2003; Bawden et al., 1999).  
The genome organisation and current classification are interlinked, as the two 
genera are defined by the monopartite (Betatetravirus) or bipartite (Omegatetravirus) 
nature of encapsidation (Fig 1.3 A).  Members of the Betatetravirus genus express 
the replicase (5’ ORF) and the capsid protein precursor α (3’ ORF) from one RNA 
strand, utilising a sub-genomic RNA for expression of the capsid protein precursor 
(VCap), which may also be encapsidated (Fig 1.3 A).  The type species of this genus 
is the Nudaurelia capensis beta virus (NβV) while PrV is unique in that it encodes a 
third open reading frame (ORF), designated p130, which is the first ORF at the 5’ 
end of the viral genome (Fig 1.3 A and C).  Whether p130 is expressed and how it 
functions in the viral life cycle, is unknown (Gordon et al., 1999; Walter et al., 2010).   
 
In species belonging to the genus Omegatetravirus, the replicase and VCap are 
encoded by two separate genomic RNAs, RNA 1 and RNA 2 respectively, both of 
which are encapsidated within the same particle (Fig 1.3 A).  In addition to the 
replicase, the RNA 1 of the omegatetraviruses also encodes three small proteins 
overlapping with the replicase ORF at its 3’ end (Dorrington et al., 2011).  The 
expression of these proteins and their function in the viral lifecycle is yet to be 
elucidated.  A further ORF encoding a protein of 17 kDa (p17) is found upstream and 
overlapping with the VCap ORF on RNA 2 (Dorrington et al., 2011).   The position of 
the p17 ORF and its amino acid sequence is conserved in all three 
omegatetraviruses, alluding to a common function (Du Plessis et al., 2005; Hanzlik et 
al., 1995; Yi et al., 2005).  The p17 ORF is preceded by a poor translation context 
and the predicted amino acid sequence contains a high proportion of Pro-Glu-Ser-
Thr amino acids, collectively known as PEST signals (Reichsteiner and Rogers, 
1996; Kozak; 1987; Hanzlik et al., 1995).  This data prompted Hanzlik and 
colleagues to propose that p17 might be a movement protein or function in regulating 
viral replication (Hanzlik et al., 1995).  The Dendrolimus punctatus tetravirus (DpTV) 
p17 has been shown to bind RNA.  The study by Zhou et al. (2008) showed that 
recombinant p17 bound viral RNA 2, but also exhibited non-specific binding to non-
viral ssRNA, dsRNA and DNA.  The authors speculated that the protein was involved 
in regulating viral RNA replication (Zhou et al., 2008). 
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As mentioned, the name Tetraviridae is derived from the T=4 capsid symmetry of the 
particles (Finch et al., 1974).  Yet despite commonality regarding the structure of the 
capsids, the replicase proteins used by different species within the family can be 
separated into three major families.  For this reason the Tetraviridae is being re-
classified into three new families based on the sequence of the replicase proteins 
(Fig. 1.3).  The new families are as follows: (1) The Alphatetraviridae (Fig 1.3 A), 
which will consist of the two genera mentioned previously, Betatetravirus 
(monopartite) and Omegatetravirus (bipartite); (2) the Permutotetraviridae (Fig 1.3 
B), which will only contain two species, Thosea asigna virus (TaV) and Euprosterna 
elaeasa virus (EeV), and have been separated from the alphatetraviruses on the 
basis of an internal permutation on the replicase and the lack of methyl transferase 
and helicase domains on the protein and (3) the Carmotetraviridae (Fig 1.3 C), which 
will comprise the monopartite PrV and also lack the methyl transferase and helicase 
domains but encodes a carmo-like replicase (Dorrington and Short, 2010). 
 
11 
 
 
 
Figure 1.3: Genome organisation of the re-classified Tetraviridae.  (2A) refers to 
the 2A-like processing sequences and (*) the read through stop codons.  The 
conserved domains of the replicase proteins are refered to as MT for methyl 
transferase domain, HEL for the helicase domain and RdRp for the RNA-dependant 
RNA polymerase domain.  Bent arrows indicate the start of a subgenomic RNA 
species.  HaSV – Helicoverpa armigera stunt virus, DpTV – Dendrolimus punctatus 
tetravirus, NβV – Nudaurelia capensis beta virus, EeV – Euprosterna elaeasa virus, 
TaV – Thosea asigna virus, PrV – Providence virus (Adapted from Dorrington and 
Short, 2010). 
A 
 
B 
 
C 
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Capsid assembly 
The novel nature of the structure of the T=4 tetravirus capsid has meant that a great 
deal of research has been undertaken regarding capsid assembly.  The first 
tetravirus crystal structure was developed by Cavarelli and colleagues in 1991.  The 
structure of the Nudaurelia capensis omega virus (NωV) capsid at 2.8 Å resolution 
was the first description of a virus in which 240 copies of a single protein made up a 
capsid with T=4 symmetry (Fig. 1.4).  The T=4 nature of the particle thus means that 
there are four separate conformations of the capsid proteins, described as subunits 
A, B, C and D.  Therefore, when compared to the other viruses in the T=3 assembly 
category mentioned above, tetraviruses contain one extra conformation (Cavarelli et 
al., 1991).   
 
 
 
Figure 1.4: Structure of NωV.  NωV is the current type species of the genus 
Omegatetravirus and the capsid is characterised as T=4 due to the four separate 
quasi-equivalent conformations that the capsid protein takes up.  These are 
designated A (blue), B (red), C (green) and D (yellow).  A complete particle is 
assembled from pentamers, formed by the interaction of A subunits (blue) to each 
other, and quasi-hexamers, formed by the pairing of B (red), C (green) and D 
(yellow) subunits (Carillo-Tripp et al., 2009; NωV: 
http://viperdb.scripps.edu/info_page.php?VDB=1ohf). 
 
During assembly, tetravirus capsid dimers assemble into an alternating series of 
pentamers and quasi-hexamers to form the capsid shell.  Five copies of the A 
subunit form the pentamers while pairs of B, C and D subunits form the quasi-
hexamers (Fig. 1.4).  Initially this particle exhibits a swollen immature form called a 
procapsid.  The procapsid then undergoes maturation which coincides with a drop in 
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pH, which in turn promotes the protonation of specific residues on VCap (Canady et 
al., 2000).  The orientation of these residues in relation to an Asp-Phe pair within the 
capsid core is thus changed, making this bond sterically unfavourable.  Maturation 
thus occurs via the autoproteolytic cleavage of the Asp-Phe peptide bond in all 240 
copies of the capsid protein, resulting in major (β) and minor (γ) capsid proteins that 
remain part of the mature particle (Dorrington et al., 2011).   
 
Extensive analysis of the tetravirus procapsid using cryo-EM has shown that NωV 
procapsids are rounder, larger in diameter, perforated and contained different 
conformations of the internal and external protein domains when compared to the 
mature capsid (Canady et al., 2000).  In this regard, a link was made to the swollen 
form of the bromoviruses TBSV and CCMV and it was noted that these viruses also 
utilise a protein dominated molecular switch (Canady et al., 2000).  X-ray scattering 
was used to analyse the unique properties of the procapsid (Canady et al., 2001).  
From these experiments it was shown that the procapsid is an independent stable 
structure at pH 7.6 and undergoes a complete maturation at pH 5.0 within seconds.  
The conformational change seems to facilitate the cleavage reaction and conversely 
this reaction can take as long as 96 hours to complete but is irreversible if more than 
15 % of the residues are already cleaved per capsid (Canady et al., 2001).  Specific 
mutations at key residues around the cleavage site have shown that these capsids 
are able to revert back to the procapsid state when the pH is reversed back to 5 from 
7.6 (Taylor et al., 2002).   
 
The experiments described above have prompted the maturation reaction to be 
described as a “pH-driven machine” involving the molecular switch (schematically 
represented in Fig. 1.5).  The C-terminal region of the C and D subunits which will 
represent the wedge between flat contacts (molecular switch) acts as the engine, 
while the remainder of the capsid subunits act as the cargo (Taylor et al., 2002).  
After a drop in pH, these key helices are converted to coils via the protonation of 
amino acids around this area.  The coils are consequently small enough to act as the 
wedge between capsid subunits and thus flat instead of bent contacts are created.  
Taylor et al. (2002) proposed that this may also explain the evolution of the cleavage 
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reaction post-assembly, as it uncouples the engine from the cargo and thus when 
the particle has been formed into a mature capsid, the pH has no bearing on its 
structure and it is thus “locked” in place.  Evidence from experiments where the pH 
of maturation was carefully controlled via titration have shown that pH is not 
necessarily required for the chemistry of the cleavage reaction but is required for the 
protonation of the domains around the active site, thus ensuring that it is accessible 
for the auto-proteolytic reaction (Matsui et al., 2009). 
 
 
 
Figure 1.5: Representation of the “pH-driven machine” controlling maturation 
of tetravirus particles.  The region of the helical domain responsible for maturation 
in NωV is residues 1 – 44 and 571 – 644.  The core of the capsid precursor protein is 
represented by an empty rectangle.  The internal helical region is either represented 
as a helix (empty square) or a coil (filled in circle).  (a) The procapsid is a porous 
structure isolated at pH 7.6 in which the internal helical regions are in the helix 
conformation.  (b)  Upon reduction to pH 5, protonation of key residues institutes 
conformational changes in the internal region that result in the helices being 
converted to coils.  (c) Without cleavage the procapsid to capsid state is reversible 
but upon cleavage the engine (γ peptide) of the “machine” is separated from the 
cargo (rest of the protein).  (d) The capsid is thus locked in position and shifts in pH 
between 5 and 7.6 can alter the state of the internal helical region without affecting 
the capsid structure (Reproduced from Taylor et al., 2002). 
   
Unfortunately, further analysis of the assembly of tetraviruses is hampered by the 
fact that they are not infectious in cell culture.  For this reason a variety of alternate 
strategies and systems have been employed to produce virus-like particles (VLPs) 
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that can be used to map the T=4 structure of the capsids.  Non-infectious NωV VLPs 
that are structurally indistinguishable from the wild type particle have been produced 
by the baculovirus mediated expression of the VCap ORF in insect cells (Agrawal 
and Johnson, 1995; Taylor et al., 2002; Maree et al., 2006).  HaSV VLPs (which are 
also non-infectious) have also been produced from yeast as well as plant expression 
systems, involving Nicotiana plumbaginifolia protoplasts (Tomasicchio et al., 2007; 
Gordon et al., 2001). 
 
Tetravirus research has progressed to a point in which the structure of the particles 
and mechanisms of assembly are relatively well understood.  Despite this, the 
mechanisms behind specific packaging are unclear.  It is therefore, important to look 
at other examples of viruses in which assembly and packaging have been analysed 
side by side, to establish some idea of how tetraviruses may encapsidate their 
genomes. 
 
1.5 Bromoviruses 
Plant viruses have historically been effective systems for studying virus assembly 
and thus packaging for four major reasons.  Firstly, their particles were some of the 
first for which near atomic resolution structures were acquired; secondly, their 
assembly mechanisms are simple enough to manipulate when compared to their 
animal counterparts; thirdly, their assembly and packaging mechanisms can be 
studied in vitro, data of which has been shown to be applicable in vivo and, finally, 
the full length cDNA of these viruses is infectious and many constructs are available 
(Fox et al., 1994).  Investigations into how the structure and assembly of 
bromoviruses affected the packaging of their genomic RNA represents one of the 
largest bodies of packaging literature to date (Yi et al., 2009; Kao et al., 2011)   
 
Bromoviruses have been at the vanguard of assembly and packaging for many 
years.  They are (+) ssRNA plant viruses with T=3 capsid symmetry (Fox et al., 
1994).  The family Bromoviridae forms part of the alphavirus-like superfamily and 
consists of six genera (Bujarski et al., 2011).  The genome of these viruses is 
16 
 
segmented into three separate messenger sense RNAs.  RNA 1 and 2 encode 1a 
and 2a proteins that together are essential in RNA replication.  RNA 3 is dicistronic, 
encoding both the movement protein, known as the 3A protein (5’ ORF) and the 
capsid protein (3’ ORF) (Alquist, 1994).  The capsid protein is expressed via a 
subgenomic RNA which is co-encapsidated with RNA 3.  RNA 1 and 2 are 
encapsidated into separate particles (Rao, 2006).  The assembly and packaging 
pathways of these viruses is thus complicated by the fact that not only do they need 
to select viral RNA but they need to ensure that four separate viral RNAs are 
packaged into separate particles.  It would appear that assembly is RNA dependant 
due to the fact that no empty virus particles have been documented in wild type 
preparations (Kao et al., 2011).  The majority of the understanding of the assembly 
and packaging mechanisms of this family has come out of the study of two viruses; 
BMV (Fig. 1.6 A) and CCMV (Fig. 1.6 B).  
  
A 
 
B 
 
  
Figure 1.6: Structure of BMV (A) and CCMV (B).  Similar subunit conformations of 
the capsid proteins are depicted in the same colour coding as Fig. 1.4; ie. subunit A 
– blue, B – red and C – green.  Both bromoviruses are made up of pentemers 
formed between the A subunits and hexamers between B and C.  Each protein is 
quasi-equivalent to its neighbour (Carrillo-Tripp et al., 2009; BMV: 
http://viperdb.scripps.edu/info_page.php?VDB=1js9; CCMV: http://viperdb.scripps. 
edu/info_page.php?VDB=1za7). 
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Capsid assembly 
CCMV was the first virus to be fully assembled in vitro and this work effectively kick-
started the study of virus assembly (Bancroft et al., 1969).  It was observed that 
generally, particles were stable at low pH (5.0) and high ionic strength but that when 
the pH was increased to 7.0 while lowering the ionic content, a swollen form of the 
particles resulted and upon further increase in pH (above 7.5), the particles 
completely disassembled into 40S ribonucleoprotein complexes and capsid protein 
dimers (Bancroft et al., 1969).  This study represented the initial framework on which 
to model bromovirus assembly and was the first indication that a ribonucleoprotein 
complex and capsid protein dimers may represent the basic assembly units.   
 
Some years later, high resolution structures for both CCMV and BMV were resolved 
at 3.2 Å and 3.4 Å, respectively (Speir et al., 1995; Lucas et al., 2002).  The structure 
of both sets of viruses was similar in that 180 units of the capsid proteins were 
combined into sets of quasi-equivalent dimers (A/B, C/C) making up asymmetric 
pentamers and hexamers forming a T=3 particle (Fig. 1.6).  The general structure of 
the viruses and the polymerization of their capsid proteins during assembly is similar 
to that of the tetraviruses and nodaviruses, as the N and C termini both play a role in 
tethering one protein subunit to the other (Speir et al., 1995).  This was 
independently corroborated by Zhou et al. (1995) who were able to show that N and 
C termini deletion mutants of CCMV capsid proteins expressed in Escherichia coli 
(E. coli) resulted in a variety of assembly defects when assembled in vitro.  Taken 
together and given the evidence of many subsequent studies, it is hypothesised that 
assembly starts with dimerization of the capsid proteins, which itself involves 
interaction between the C terminal 179 – 190 amino acids of each subunit which are 
then clamped together and stabilised by the first 49 amino acids of the N terminal 
(Speir et al., 1995).  The dimers then combine to form hexamers between the B and 
C subunits or pentamers between the A subunits, to which additional dimers are 
added (Fig. 1.7).  The hexmeric structures are known as β-hexamers.  RNA binding 
is thought to occur early on in the process at either the dimer or β-hexamer interface 
and acts as the molecular switch to induce curvature at certain contacts (Kao et al., 
2011).  In this way the addition of RNA or nonRNA-bound subunits effectively 
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initiates the choice between either a bent or straight contact between the capsid 
subunits allowing for the assembly of a closed shell, while simultaneously packaging 
the genome. 
       
A 
 
B 
 
       
Figure 1.7: Structure and assembly of CCMV.  The same colour coding strategy is 
used as for Fig. 1.4.  (A) The basic assembly unit is made up of dimers of the same 
19.4 kDa capsid protein (shown between subunits B and A or C and C) that combine 
to form a β-hexamer structure.  The top half of (A) depicts a ribbon diagram of the 
process (note the N and C terminal tails extending away from the jelly-roll core in 
order to facilitate binding to the next subunit), while the bottom half is a diagrammatic 
representation. (B)  Diagrammatic representation of the final T=3 capsid particle.  
(Reproduced from Speir et al., 1995) 
 
The interaction between RNA and protein plays an essential role in the formation of 
the infectious particle, yet interestingly the same induction of particle formation in 
bromoviruses can be mimicked by many polyanions, including various RNAs and 
dextran (Bancroft et al., 1969).  Following on from this work, Cuillel et al. (1979) was 
able to show that Alfalfa mosaic virus (AMV) 12S RNA could effectively replace 
Bromegrass mosaic virus subgenomic RNA in capsid particles indistinguishable from 
the wild type, although it was noted that when placed in direct competition for 
encapsidation the wild type subgenomic RNA effectively outcompeted 12S AMV 
RNA to the extent that only 20 % of the heterologous RNA was packaged in vitro 
(Cuillel et al., 1979).  This indicated that the ionic characteristics of the molecule 
being packaged play a role in the initiation of assembly, but that selective packaging 
(a) 
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mechanisms are present to ensure that the bromoviruses encapsidate the correct 
RNA (Cuillel et al., 1979). 
 
Packaging 
As mentioned earlier, the N-terminus of the capsid proteins of both BMV and CCMV 
contain regions rich in positively charged arginine residues, known as ARMs (Speir 
et al., 1995; Lucas et al., 2002).  These regions have been implicated in ensuring 
that each capsid particle contains either RNA 1, 2 or 3 and the subgenomic RNA.  
Despite this, evidence using whole plant infection assays has been somewhat 
contradictory.  When plants were infected with functional RNA 1, 2 and 3 as well as 
mutant subgenomic RNA in which the codons for four of the arginines in the ARM 
were mutated to prolines, packaging defects of only the subgenomic RNA were  
observed (Choi and Rao 2000a).  The well-established in vitro system was used to 
reassemble these mutant viruses and it was shown that despite assembling into T=3 
particles, the subgenomic RNA packaging defect was maintained in vitro.  As 
mentioned before, icosahedral virus assembly is dependent on the interaction of the 
capsid protein with the RNA and thus it was interesting to note that without the ARM 
the capsid was still able to assemble RNA 1, 2 and 3 particles.  Instead of disrupting 
total RNA packaging, only the signal required for RNA 4 packaging was disrupted 
(Choi and Rao 2000a).  This data implies that the selection of RNA is distinct from 
the assembly mechanism.  These conclusions were supported by the observation 
that chimeric TMV (family: Tobamoviridae) with BMV coat proteins effectively 
packaged all the subgenomic RNAs generated by the TMV genome (Choi and Rao 
2000b).  The results suggested that the ARM must be able to recognise a region (of 
which both primary and secondary structure may be important) contained on its own 
open reading frame and that RNA 1, 2 and 3 must have similar regions in order to be 
packaged (Choi and Rao 2000b).  The binding of the RNA to the ARM is not 
necessarily specific and thus the virus requires some other mechanism to ensure 
RNA specificity (Choi and Rao 2000b). 
 
In 2003, a dynamic model for the packaging of CCMV was postulated, based on in 
vitro RNA binding assays and gel shift data (Johnson et al., 2003).  By combining 
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RNA 1 with varying concentrations of the capsid dimers, two distinct shift profiles 
were observed: (1) a fast pathway occurring after just twenty minutes at 
approximately stoichiometric binding of ninety dimers and (2) a slow pathway, only 
being evident after twenty-four hours.  The fast pathway resulted in a characteristic 
nucleoprotein complex that resembled wild type RNA binding, while the slow 
pathway had a bimodal gel shift in which some RNA formed wild type complexes 
while another portion migrated quicker than RNA 1 alone.  This was called complex 
1 (C1) and it was concluded that RNA folding instead of degradation must have been 
responsible for its formation and migration (Johnson et al., 2003).   
 
 
 
Figure 1.8: Model for the specific packaging of RNA 1 into CCMV particles.  
The diamonds represent capsid protein dimers and the single line RNA 1.  At low 
protein concentrations, the dimers find high affinity RNA binding sites on the viral 
RNA and bind.  This allows the ribonucleoprotein complex to fold into C1.  This initial 
binding is at low cooperativity, given the lower capsid protein concentration and 
therefore progresses slowly.  Once viral RNA is “labelled” as C1, then a high 
cooperativity binding of additional dimers results and the assembly of the capsid 
particle can be completed (Taken from Johnson et al., 2003). 
 
A model which takes advantage of the differing concentrations of RNA and capsid 
protein at differing points during infection has been proposed by Johnson et al. 
(2003).  According to the model (see schematic diagram depicted in Fig. 1.8),  at the 
initial stages of infection, when the RNA concentration is high but the coat protein 
dimer concentration is limiting, the conditions, are conducive for the coat proteins to 
scan RNA to find high affinity viral RNA binding sites.  As the dimers find viral RNA, 
they slowly fold into C1.  This allows time for the capsid protein concentration to 
increase, while viral RNA is “tagged” by its formation of a C1 complex.  Capsid 
dimers thus preferentially bind C1 over other RNA molecules and the addition of 
subsequent dimers and hexamers to C1 will form a virus particle.  In this way coat 
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protein effectively labels viral RNA, described as a “structural identifier” (Johnson et 
al., 2003).  In separate studies there is evidence that the coat proteins of CCMV and 
BMV have been proposed to regulate replication and translation by binding other 
regions of the RNAs (Yi et al., 2009; Zhu et al., 2007).  Although it is not clear how all 
these processes may function together, it is interesting to note that assembly, 
replication and translation have been linked to RNA-capsid protein binding.  Future 
experiments may elucidate a linkage between all these processes.  The C1/ 
“structural identifier” model predicts that it would be possible for heterologous RNA to 
initiate C1 (by non-specific binding to the capsid protein) and thus be incorporated 
into particles as was seen in a study with Xenopus elongation factor RNA and yeast 
tRNA by Krol et al. (1999).  Yet it also predicts that in competition, capsid precursor 
dimers should select bromovirus RNA over heterologous RNA, as was observed by 
Cuillel et al. (1979).  The advantage of the bromovirus packaging system would be 
that no specificity of the ARM is required for specific packaging of RNA.  To date, no 
C1 complex with wild type RNA 2 and 3 has been detected, suggesting either that 
differing mechanisms are involved in their packaging or that there is some 
requirement for RNA 1 packaging first (Annamalai et al., 2005). 
 
Choi and Rao (2003) identified a bipartite signal on BMV RNA 3 that seems to be 
essential for its packaging into a virus particle.  The tRNA-like structure, found on the 
3’end of all bromoviral RNAs, was described as a nucleating element while a 187 nt 
double stem and loop region within the movement protein ORF represented the 
packaging element.  It was shown that the combination of these signals was required 
for the packaging of RNA 3 into BMV particles.  An intriguing feature of this 
observation is that all bromoviral RNAs share the tRNA-like structure on the 3’ end of 
the RNA and thus its combination with a distinct signal on each viral RNA could act 
as a mechanism to incorporate separate RNAs into separate virions (Choi and Rao, 
2003).   
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1.6 Nodaviruses 
A variety of insect viruses have also recently been used as model systems to study 
packaging and assembly.  The capsid structure and symmetry of the nodaviruses is 
relatively similar to that of the bromoviruses and tetraviruses, thus as could be 
expected, the basic mechanism of assembly is as well.  Yet surprisingly, despite the 
similarities, the way in which insect viruses regulate the selective packaging of their 
genomic RNA appears markedly different.  This could be because insect cells are 
inherently different to plant cells or that insect viruses do not traditionally encode 
movement proteins and thus there is a higher premium on effective packaging to 
ensure infectious particles.  Either way, it is fascinating that the way in which two 
sets of capsid particles are formed can be the same but the packaging of the 
genomic RNA so different.  The nodaviruses are insect T=3 viruses that resemble 
the plant T=3 structure (Thiéry et al., 2011).  This family is related to the tetraviruses 
via similarity in the amino acid sequence of the capsid proteins and consequently, 
despite the difference between T=3 versus T=4 capsid symmetry, the two families 
are structurally also related.  Given this relationship, nodaviruses provide another 
potential source of clues for tetravirus packaging and it is thus fortunate that recently 
a great deal of focus has been placed on nodavirus assembly and packaging (Thiéry 
et al., 2011). 
 
Nodaviruses are also (+) ssRNA viruses (Thiéry et al., 2011).  These viruses infect a 
variety of insect species and have intriguingly also been isolated from fish (Mori et 
al., 1992; Thiéry et al., 2011).  The family is made up of only two genera, namely 
Alphanodavirus and Betanodavirus. The differentiating element between these two 
genera is that nodaviruses isolated from insects are placed into the Alphanodavirus 
genus whereas those isolated from fish are defined as betanodaviruses (Thiéry et 
al., 2011).  Nodavirus particles generally have a diameter of between 25 – 30 nm.  
The genome is bipartite, consisting of RNA 1 encoding Protein A (the replicase) and 
RNA 2, which encodes protein α (the capsid precursor protein) (Friesen and 
Rueckert 1981; Thiéry et al., 2011).  A separate subgenomic RNA 3 has been 
detected in infections of both fish and insects and is synthesised from the 3’ end of 
RNA 1.  This strand is not packaged by the nodavirus particles (Eckerle and Ball, 
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2002).  This RNA is responsible for the expression of two proteins, named B1 and 
B2.  Recent evidence has revealed that despite very little sequence homology, the 
B2 protein of both alpha and betanodaviruses functions as a novel host immune 
system repressor (suppressing RNA silencing) while the function of B1 is unknown 
(Sullivan and Ganem, 2005; Qi et al., 2011).  Both RNA 1 and 2 are packaged into a 
single particle made up of 180 subunits of protein α (Krishna and Schneemann, 
1999).  Like the tetraviruses, protein α is cleaved post-assembly into two mature 
capsid proteins, β and γ, that remain part of the capsid (Gallagher and Rueckert, 
1988).  This represents a distinctive difference between the assembly of the insect 
viruses and the symmetrically similar plant viruses.  The story of assembly and 
packaging in nodaviruses is another example of how recently developed, 
sophisticated molecular techniques have been employed together with equally 
sophisticated classical structural biology to map out in detail the mechanism of 
nodavirus particle assembly. 
 
Capsid assembly 
 The crystal structures of three alphanodaviruses have been determined to the same 
3.0 Å level of resolution; these include Black Beetle virus (BBV – Fig. 1.9 A), Flock 
House virus (FHV – Fig. 1.9 B) and Pariacoto virus (PaV – Fig. 1.9 C) (Hosur et al., 
1987; Fisher and Johnson, 1993 Tang et al., 2001).  The structure of each of these 
particles is essentially the same in that it is made up of 180 subunits of the capsid 
precursor protein α.  In the same way as the plant T=3 viruses, each protein 
occupies a quasi-equivalent environment distinguished by slightly different 
conformations, designated A, B and C (Fig. 1.9).  However, unlike bromoviruses and 
similarly to the tetraviruses, the particle initially assembles into an immature particle 
or provirion, characterised by a porous capsid structure (Gallagher and Rueckert 
1988; Schneemann et al., 1992) Once the provirion has formed, the immature 
particles undergo autoproteolytic cleavage between an Asn-Ala pair (Asn-Ser in 
PaV) at a site deep inside the virus core, which results in the mature β and γ capsid 
proteins (Hosur et al., 1987; Tang et al., 2001).  The β protein is the larger of the two 
as the γ protein is only coded for by the last 40 - 50 amino acids of the precursor 
protein (Friesen and Rueckert, 1981).  The cleavage is proposed to increase the 
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stability of the particle and also make it infectious (Schneemann et al., 1993).  
Mutations, in which cleavage is abolished by changing the amino acids at the 
cleavage site of FHV, have resulted in non-infectious particles, implying that 
cleavage is also essential in assembly (Schneemann et al., 1993). 
 
A 
 
B 
 
C 
 
  
Figure 1.9: Structure of BBV (A), FHV (B) and PaV (C).  The same colour coding 
strategy is used for the capsid proteins of Fig. 1.4.  The structure and assembly of 
the nodaviruses shares the same T=3 symmetry of the bromoviruses and is thus 
also formed by pentamers of A subunits and hexamers of B and C (Carrillo-Tripp et 
al., 2009; BBV: http://viperdb.scripps.edu/info_page.php?VDB=2bbv; FHV: 
http://viperdb.scripps.edu/info_page.php?VDB=2z2q; PaV: http://viperdb.scripps.edu/ 
info_page.php?VDB=1f8v).   
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Despite the assembly of a provirus, the mechanism by which nodavirus particles 
assemble is similar to that of the bromoviruses discussed above (Dong et al., 1998; 
Fisher and Johnson, 1993; Tang et al., 2001).  Essentially it is believed that a trimer 
of dimers (in the α conformation) makes up the basic assembly unit.  At some point 
during dimerisation RNA is incorporated, therefore, even though nodaviruses form 
provirions/procapsids, the procapsid pathway of packaging is not utilised in favour of 
making ribonucleoprotein complexes.  These complexes are formed when 
pentamers of capsid protein dimers, formed by the tethering together of subunits at 
their N-terminus, attach to RNA and then to one another.  Just as in the 
bromoviruses, the N subunit of one of the capsid conformations, namely subunit A, 
folds around the trimer interface and fits into a groove between B or C in which it 
stabilises the RNA.  The crystal structure and amino acid sequence also show that 
the C-termini (γ peptide) of each of the subunits have extensive interactions with the 
RNA, although whether this is the initial RNA binding site for each trimer is still to be 
determined (Fisher and Johnson, 1993; Tang et al., 2001).  Upon binding the RNA, 
the capsid proteins differentiate into either A, B or C conformations and are all 
connected by bent contacts.  Interaction with the RNA results in some flat contacts 
forming instead of bent contacts and in this way, with the help of additional non-
specific RNA interactions with more dimers, an icosahedral T=3 nodavirus particle is 
formed (Fig. 1.10) (Fisher and Johnson, 1993; Tang et al., 2001; Thiéry et al., 2011).  
Thus the RNA together with the N-terminal of the γ peptide is essential as the 
molecular switch in nodavirus assembly.  This model is supported by evidence that 
when amino acids 1 – 50 of the N-terminus or the entire γ peptide of the capsid 
protein were deleted in FHV, no assembly of VLPs resulted (Schneemann and 
Marshall, 1998; Dong et al., 1998). 
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Figure 1.10: Capsid protein-protein and protein-RNA interactions essential in 
FHV assembly.  (A)  Schematic diagram of the FHV T=3 structure made up of the 
capsid protein in A, B and C conformations.  The dsRNA duplex bound to the ARM 
of peptide C is depicted in the centre.  (B)  The dsRNA bound to the ARM of the γ 
peptides (dark black alpha helices), acts as a wedge thus ensuring that the contact 
between subunits C and B is flat.  (C) Conversely the lack of RNA means that the A 
and C contact is bent (ribbon diagram below).  This makes RNA the molecular switch 
during nodavirus assembly (Reproduced from Fisher and Johnson, 1993).  
  
The high resolution structures of FHV and PaV have revealed the structure of the 
RNA within their capsids (Fisher and Johnson, 1993; Tang et al., 2001).  These have 
shown that the RNA forms an ordered duplex dodecahedral cage with its own 
symmetry mimicking the T=3 symmetry of the capsid (Fig. 1.11) (Fisher and 
Johnson, 1993; Tang et al., 2001).  The model generated for the structure of PaV 
showed furthermore that approximately 30 head to tail duplexes are connected to the 
capsid proteins (and thus could be seen in the crystal structure) and make up 35% of 
the packaged RNA, while the remaining 65% bulk RNA was connected to the cage 
but lay in the interior (Fig. 1.11) (Tang et al., 2001).   These observations provide 
additional support for the importance of RNA as more than just the molecular switch, 
as the symmetry of the RNA within the core was shown to exert its own pressure on 
the protein structure.  This is described as “reciprocal influence” and indirectly 
corroborating evidence has shown that when the size of the RNA to be packaged 
changes, so does the structure of the particle (Dong et al., 1998; Marshall and 
Schneemann, 2001).  Therefore, this line of research was one of the first to show 
that not only does RNA have an effect on initiating the assembly process but that 
there is also a dynamic relationship between the packaged RNA and the capsid 
proteins.  Although, this does not necessarily imply packaging specificity as the 
C 
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dodecahedral RNA cage was still detected when FHV and PaV VLPs were made 
containing exclusively cellular RNA (Johnson et al., 2004).  Yet the similarities end 
here as the mechanism of packaging of nodavirus particles is remarkably different 
from that of their plant counterparts. 
 
 
 
Figure 1.11: Cryo-EM three–dimensional reconstruction of both the protein and 
RNA components of PaV.  (A)  The protein component of the PaV particle was 
modelled via the crystal structure determined to 3.0 Å of resolution.  (B) A difference 
map was generated by subtracting the signal responsible for protein with that of the 
RNA and was able to reveal the duplex RNA dodecahedral cage (gold) mimicking 
the symmetry of the T=3 protein capsid.  Bar = 100 Å (Taken from Tang et al., 2001).  
 
Packaging 
The story of nodaviral packaging starts with the observation by Schneemann and 
Marshall in 1998 that when the portion of the γ peptide (C-terminal region) not visible 
in the X-ray structure of FHV was deleted, particles similar to wild type particles 
resulted, but the VLPs packaged random cellular RNA.  The same phenomenon was 
observed when a smaller N-terminal deletion was made instead of that of the C-
terminal (Dong et al., 1998). Therefore surprisingly, as was observed for 
bromoviruses, the nodavirus assembly mechanism is relatively promiscuous with 
regards to RNA-capsid binding.  Once again, a specific mechanism must exist as 
two sets of RNA are consistently and specifically encapsidated by one particle in wild 
type infections (Schneemann et al., 1994).  This data led to the assumption that both 
the N and C termini of the capsid protein were not only crucial during the assembly 
pathway but that certain regions within each terminus played a role in selecting the 
RNA in the first place (Schneemann et al., 1994; Dong et al., 1998).   
A 
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Subsequent studies showed that a key piece was missing from the nodavirus 
packaging puzzle.  In the previous experiments only RNA 2 had been expressed in 
insect cells (Schneemann et al., 1994; Dong et al., 1998).  In 2001 when Marshall 
and Schneemann repeated the same experiment with wild type RNA 1 and the N-
terminal deletion mutant of RNA 2, the resulting VLPs efficiently packaged RNA 1 to 
wild type levels and RNA 2 less efficiently.  Due to the fact that RNA 1 is able to 
kickstart replication of both itself and RNA 2 in insect cells, this led to the hypothesis 
that packaging and replication are linked in nodaviruses (Marshall and Schneemann, 
2001).  In the same study it was shown that instead of only RNA 2, smaller defective 
interfering (DI) RNAs were also being packaged, despite replication by RNA 1.  This 
led to the additional conclusion that the N-terminus of the capsid protein is important 
in recognising RNA 2 and that the packaging pathways of RNA 1 and 2 must be 
distinct (Marshall and Schneemann, 2001).  These results were substantiated by 
studies done later by the same group in which the construction of baculoviral vectors 
containing full length RNA 1 and 2 with C-terminal ribozyme sequences (to ensure 
the transcription of precise 3’ ends) was reported.  When both baculoviruses were 
infected into the Spodoptera frugiperda 21 (Sf21) insect cell line, replicating FHV 
particles resulted that packaged wild type RNA to almost identical wild type virus 
levels (Krishna et al., 2003).  Furthermore it was shown that when the RNA 1-
expressing  baculovirus was mutated so that replication was inhibited, the packaging 
of the VLPs reverted back to the heterologous cellular phenotype and, therefore, it is 
the activity of replication that is required for packaging and not RNA 1 alone (Krishna 
et al., 2003).   
 
Yet another interesting feature of nodaviral packaging was elucidated in this study, 
namely that the timing of expression is important for the packaging of genomic 
versus cellular RNA.  When RNA 2 was transfected 24 hours after infecting with the 
RNA 1 baculovirus, VLP packaging was indistinguishable from wild type packaging, 
eliminating the small amounts of DI RNAs that were previously packaged in some 
particles (Krishna et al., 2003).  This experiment, which mimicked more closely the 
timing of transcription within FHV infected cells, showed that although packaging and 
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assembly can be directed by cellular RNA, there is some mechanism that maintains 
specificity. 
 
A hypothesis on how nodaviral packaging specificity may come about has been 
proposed in recent years (Venter et al., 2009).  This hypothesis initially originated 
from the results of an experiment where the capsid protein was introduced into the 
FHV replicating tissue culture system in cis or in trans.  When the capsid protein was 
provided in trans to non-replicating RNA, neither RNA 1 or RNA 2 was packaged but 
when the capsid protein was made from a replicating RNA 2 (and provided in cis) 
then its packaging became efficient, regardless of the replication state of RNA 1.  
Therefore, the capsid protein needed to be translated off a replicating RNA in order 
for it to initiate packaging and thus it was concluded that translation is also linked to 
the replication-packaging pathway (Venter et al., 2005).  The authors of this study 
proposed that the means by which RNA 2 translation-replication and packaging 
could be interlinked was via the environment which the RNAs take up in the cell.  
This therefore, gave rise to the new model for the spatial coordination of packaging 
in nodaviruses (Venter et al., 2005).    
 
It was proposed that FHV makes a specialised microenvironment within the cell 
where the replication of RNA 1 and 2 can be in close proximity to the translation of 
the capsid protein precursor.  This means that the capsid protein can snatch RNAs 
as they are replicated and that the fact that they are being replicated ensures 
packaging specificity (Venter et al., 2005).  Thus the entire assembly and packaging 
process may hinge on the replication of RNA 2, as it is the location of its replication 
and thus translation that defines what it packages (Venter et al., 2005).  If assembly 
is initiated by the contact of RNA and protein then it followed that assembly too 
would be linked to the replication-translation-packaging pathway.  This was elegantly 
proven by Venter and Schneemann in 2007 where they were able to show that two 
separate populations of particles could be produced in the same cell.  One 
population was made from replicated RNA and packaged viral RNA while the other 
was made from non-replicating RNA and consisted of mainly cellular RNA (Venter 
and Schneemann, 2007).   
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The site of FHV RNA replication has been well characterised and thus the current 
hypothesis is that RNA 1 and 2 are targeted to spherules formed by the invagination 
of the mitochondrial membrane (Miller et al., 2001; Venter et al., 2009).  Subcellular 
localization of both the capsid and replicase proteins was used with mutational 
analysis to extend the proposed mechanism even further.  In 2009 Venter and co-
workers showed that initially the coat protein localizes with the endoplasmic 
reticulum (ER), where it is presumably translated from RNA 2, but that at some point 
during infection it is trafficked to the mitochondria where it co-localises with the 
replicase protein.  The same study showed by mutational analysis that an ARM 
comprising residues 32 – 50 on the coat protein is critical in RNA 1 packaging.  The 
mechanism of packaging was not sequence specific as both the substitution of each 
arginine residue with lysine or the HIV ARM sequence, rescued RNA 1 packaging 
(Venter et al., 2009).  Therefore, by combining these observations it was proposed 
that RNA 2 is translated at the ER and that the ARM or some other mechanism is 
involved in combining capsid protein and RNA 2 into a nucleoprotein complex that is 
trafficked to the site of replication near the mitochondria.  This would then allow RNA 
1 to be incorporated into the fledgling particle and the non-specific pathway of 
assembly to continue to complete the capsid (Venter et al., 2009). 
 
1.7 Comparison between tetravirus and nodavirus assembly 
mechanisms 
The expression of the NωV capsid protein in insect cells provided the first line of 
evidence that tetraviruses behaved like nodaviruses, regarding the post-assembly 
autoproteolytic cleavage of a precursor protein.  Using pulse-chase experiments, 
Agrawal and Johnson (1995) were able to show that NωV initially produced a 70 kDa 
precursor protein, which was cleaved post-assembly into a 62 kDa protein plus a 7 
kDa peptide.  Following on from this work, Munshi and co-workers (1996) proposed 
that there must be an evolutionary link between nodaviruses and tetraviruses.  Not 
only was autoproteolytic cleavage conserved but cleavage also occurred between a 
similar pair of residues (Asn – Phe in tetraviruses and Asn – Ala in nodaviruses) and 
took place in the same region of the capsid protein precursor.  The capsid proteins 
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themselves are also structurally conserved when two of the three tetraviral capsid 
domains are compared (Fig. 1.12).  Therefore, it was no surprise that the assembly 
mechanism of nodavirus and tetravirus capsids is markedly similar.  
 
 
 
Figure 1.12: Comparison of the nodavirus (A) and tetravirus capsid precursor 
proteins.  The nodaviruses are represented by BBV in A and NωV in B.  The 
regions highlighted in blue represent the jelly-roll core while the regions highlighted 
in red represent the γ peptide.  A high degree of similarity between (A) and (B) can 
be seen when comparing these two domains.  One of the major differences between 
tetraviruses (B) and nodaviruses (A) is that tetravirus capsid proteins contain an 
additional immunoglobulin-like domain (gold) which is absent in nodaviruses (Munshi 
et al., 1996). 
 
Despite these similarities, two distinct features separate tetraviruses from 
nodaviruses.  Both nodavirus and tetravirus capsid proteins contain two distinctive 
domains, the jelly-roll core which is an important structural characteristic of many 
icosahedral viruses and the internal helical domains, which is made up of the N and 
C termini and are involved in molecular switching.  Tetraviruses have evolved an 
additional immunoglobulin-like domain extending from the jelly-roll core facing 
extracellularly which is all together absent in the nodaviruses (Fig. 1.12).  Secondly, 
and very importantly, tetraviruses have evolved a molecular switch that is distinct 
from that of the nodaviruses.  Where nodaviruses utilise a combination of duplex 
RNA and N-terminal helices to act like a wedge between protein contacts, 
A 
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tetraviruses have utilised a combination of the C-terminal regions of the C and D 
precursor protein subunits to effect the same function (Munshi et al., 1996; Thiéry et 
al., 2011). 
 
Recently a second tetravirus was crystallized and analysed to a 3.8 Å resolution 
(Speir et al., 2010).  PrV is the first betatetravirus for which a crystal structure is 
available and this work has revealed a very interesting feature of the evolution of this 
family.  As mentioned above, there are many structural similarities between the 
tetravirus and nodavirus capsids, while perhaps the key difference is the identity of 
the molecular switch (Munshi et al., 1996).  As has also been mentioned, PrV is a 
somewhat atypical tetravirus in that its genome does not share many of the 
characteristics typical of the tetraviruses (Walter et al., 2010).  The crystal structure 
of the PrV capsid showed that instead of using C-terminal residues of the C and D 
subunits to form the molecular switch, PrV particles utilise N-terminal residues in 
combination with duplex RNA, in a similar manner to that of the nodaviruses (Speir 
et al., 2010).  This observation prompted the hypothesis that PrV could be the 
evolutionary link between the nodaviruses and the tetraviruses and that evolution 
has acted on the molecular switch, reverting it to the opposite terminus, in order to 
maintain the same structure while accommodating another subunit into the capsid 
(Speir et al., 2010). 
 
1.8 Tetravirus packaging and the Helicoverpa armigera stunt 
virus (HaSV)  
The distinctive structural features of tetravirus particles have enjoyed much of the 
focus of research on tetraviruses to date; in contrast very little attention has been 
paid to how RNA is selected and encapsidated.  A major reason behind the lack of 
research in this area is that tetraviruses do not form infectious particles in tissue 
cultured cells (like bromoviruses or nodaviruses), thus it is difficult to determine the 
packaging pathways.  From the evidence above it would seem that equal arguments 
could be made for why packaging may be similar or very different from the 
structurally similar nodaviruses.  Indeed it would appear that at least RNA 2 
packaging is independent of replication as it was shown that NωV VLPs derived from 
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baculovirus vectors in insect cells, packaged viral mRNA 2 without being replicated 
in the cell (Agrawal and Johnson, 1995).  VLPs constructed in plant protoplasts and 
derived from the simultaneous transfection of plasmids containing full length HaSV 
RNA 1, RNA 2 and the capsid precursor (VCap) ORF, showed no sign of RNA 
replication but were infectious when fed to larvae, insinuating the specific packaging 
of RNA (Gordon et al., 2001).  This supports the hypothesis that assembly and 
packaging may be a replication-independent system in tetraviruses and thus differs 
from the mechanisms used by the nodaviruses and bromoviruses.  When only the 
coat protein message was expressed by recombinant baculoviruses, mostly cellular 
RNA was packaged (Canady et al., 2000; Taylor, 2003). 
 
One of the focuses of the tetravirus laboratory at Rhodes University is on using 
HaSV as a model tetravirus to study RNA packaging.  HaSV was first isolated in a 
laboratory reared colony of Helicoverpa armigera (commonly known as the Cotton 
Bollworm) in Australia in 1993 (Hanzlik et al., 1993).  As with most other tetraviruses, 
HaSV infects the midgut cells of H. armigera larvae, which in turn respond by 
sloughing virus infected cells, resulting in stunting of the larvae from the lack of 
nutrient uptake and eventual death (Brooks et al., 2002).   
 
HaSV consists of two (+) ssRNA molecules housed within a single capsid particle 
(Fig. 1.13).  Each RNA strand possesses a 5’ cap but no polyadenylation signal, 
which is replaced by a tRNA-like structure terminating in a 3’ hydroxyl residue 
(Hanzlik et al., 1995; Gordon et al., 1995).  RNA 1 is 5.5 Kb in size and encodes one 
major and three minor ORFs.  The major ORF (5.1 Kb) encodes a replicase protein 
of 1704 amino acids with a predicted molecular weight of 187 kDa (Gordon et al., 
1995), with the three characteristic major domains (Gordon et al., 1995).  When 
fused to the green fluorescent protein, the HaSV replicase has been shown to 
localise to membranes derived from the endocytic pathway, which have been 
proposed as the site of HaSV replication (Short et al., 2010).  The three minor ORFs 
(p11, p15 and p8) lie in a different reading frame from the replicase ORF (Gordon et 
al., 1995).  The conservation of the position and amino acid sequence of these three 
ORFs on the RNA 1 of another omegatetravirus, DpTV, suggest that they are likely 
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to have a function in the life cycle of the virus, although this has yet to be determined 
(Yi et al., 2005; Dorrington and Short, 2010). 
 
 
 
Figure 1.13: Genome organisation and translation products of HaSV.  HaSV 
capsid particles package two sets of RNA molecules.  Both sets are capped at the 5’ 
end and contain terminal 3’ hydroxyl molecules.  RNA 1 encodes the non-structural 
proteins, namely the replicase (p187) and three smaller proteins; p11, p15 and p8.  
The existence as well as the function of these smaller proteins in vivo is under 
investigation.  RNA 2 encodes the capsid precursor protein (p71) as well as p17.  
p71 otherwise known as protein α or VCap assembles spontaneously into a 
procapsid particle post-translation; each precursor protein then undergoes 
autoproteolytic cleavage during the phase of maturation to yield the major (p64 or β) 
and minor (p7 or γ) capsid proteins characteristic of a wild type capsid (adapted from 
Hanzlik et al., 1993). 
 
The HaSV RNA 2 is 2.5 kb in size and encodes two ORFs.  The larger of the two, 
codes for the capsid precursor protein (p71), this protein can also be referred to as 
protein α or the VCap protein (Hanzlik et al., 1995).  As discussed earlier (section 4) 
240 copies of the VCap protein assemble into a procapsid structure during the first 
phase of assembly and during maturation each capsid protein undergoes 
autoproteolytic cleavage at an Asn570 – Phe571 site to produce the major or β 
capsid protein of 64 kDa and the minor or γ protein of 7 kDa (Hanzlik et al., 1995).  
The presence of p64 is thus dependent on the assembly of a mature capsid particle 
and is, therefore, used as an assay for this process (Hanzlik et al., 1995; Bothner et 
al., 2005; Tomasicchio et al., 2007).  The p17 ORF precedes the VCap ORF, starting 
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at the first AUG start codon on HaSV RNA 2, is in the +2 frame and partially overlaps 
the VCap ORF.  The predicted protein consists of 157 amino acids and has a 
predicted size of 17 kDa (Hanzlik et al., 1995). 
 
Unpublished research has revealed that p17 is present in the midgut cells of 
Helicoverpa armigera larvae infected with HaSV and that the protein co-purifies with 
wild type HaSV particles at a ratio of approximately 1: 12 relative to the capsid 
protein (Vlok, 2008), suggesting that p17 might be packaged by the virus particles.  
The low p17 expression levels were shown to be due to the poor translational 
context of the AUG start codon of the p17 ORF.  These results warranted the 
establishment of a plasmid transfection system in which Spodoptera frugiperda 9 
(Sf9) cells were transfected with various constructs expressing p17 in different 
contexts with the VCap protein.  VLPs were then purified from the cells and the RNA 
content analysed.  The results showed that expression of the RNA 2 constructs that 
contained the p17 and the VCap ORFs resulted in the assembly of VLPs that 
contained viral mRNA, while VLPs assembled in cells expressing only VCap did not 
package the viral mRNA (Vlok, 2009).  In addition, it was shown that deletion of the 
5’ and/or 3’ UTR sequences of RNA 2 did not affect packaging of viral RNA (Vlok, 
2009).  These results have provided preliminary evidence that the omegatetravirus 
p17 might be involved in the packaging of viral RNA. 
 
Support for this hypothesis comes from the studies of Agrawal and Johnson (1995) 
who reported the presence of viral RNA in NωV VLPs assembled via recombinant 
baculovirus expression of an RNA 2 construct which carried the p17 ORF, while 
other studies in the Johnson laboratory have reported that VLPs assembled when 
only the omegatetravirus capsid protein precursor was expressed, packaged mostly 
cellular mRNAs and some viral mRNA.  Furthermore, the results of a study by Zhou 
et al. (2008) have suggested that the DpTV p17 may be an RNA binding protein.  
However, there are still gaps in the p17-packaging hypothesis that remain a major 
challenge.  Firstly, it was unclear from Vlok’s data whether an RNA signal, present 
on the non-overlapping region of the p17 ORF or the p17 protein itself was required 
for the specific packaging of viral RNA.  Secondly, the previous study was unable to 
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demonstrate the presence of p17 in VLPs assembled in cells co-expressing p17 and 
VCap because of the low expression levels supported by the plasmid-based 
experimental system.  Therefore, a more suitable expression system was required 
for the analysis of HaSV VLP packaging.  
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Hypothesis 
A baculovirus-mediated system will be an effective expression system for the 
production of HaSV VLPs and thus the analysis of p17’s role in RNA packaging.   
 
Aim 
The aim of this study was to develop a baculovirus expression system to determine 
whether p17 is required for the packaging of HaSV RNA 2. 
 
Objectives 
1. To confirm that the translation of p17 is required for the specificity of RNA 2 
packaging in the plasmid mediated expression system. 
2. To construct recombinant baculoviruses that co-express the HaSV capsid 
protein precursor (VCap/p71) together with p17. 
3. To determine what effect the expression of p17 has on the packaging of 
HaSV RNA 2 into VLPs derived from recombinant baculoviral vectors. 
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Chapter 2 
Materials and methods 
 
2.1 Bacterial strains 
All constructs were cloned in E. coli DH5α cells (supE44 ∆lacU1269 [ᶲ80lacZ∆M15] 
hsdR17 recA1 endA1 gyrA96 thi-1 relA1) (Hanahan, 1983) or in E. coli DH10Bac 
cells (F– mcrA Δ[mrr-hsdRMS-mcrBC] Φ80lacZΔM15 ΔlacX74 recA1 endA1 
araD139 Δ[ara leu] 7697 galU galK λ– rpsL nupG/ pMON14272/pMON7124) 
(Invitrogen).  The DH5α cells were maintained on Luria agar (LA) plates (1.0 % 
peptone, 0.5 % yeast extract, 0.5 % NaCl and 1.5 % bacterialogical agar) containing 
100 µg/µl ampicillin (LA Amp) and frozen glycerol stocks (50 % bacterial culture and 
50 % [1:1 Luria Bertani (LB) broth and glycerol mixture]) at -80 °C.  The DH10Bac 
cells were maintained in SOC medium (2 % tryptone, 0.5 % yeast extract, 0.24 % 
anhydrous magnesium sulphate, 0.05 % NaCl and 0.02 % KCl with 20 mM glucose 
added after autoclaving) pH 7.0 or on LA Bac plates containing 50 µg/ml kanamycin, 
10 µg/ml tetracycline, 7 µg/ml gentamycin, 300 µg/ml 5-bromo-4-chloro-3-indolyl-β-d-
galactopyranoside (X-Gal) and 50 µg/ml Isopropyl β-D-1 thiogalactopyranoside 
(IPTG).  E. coli BL21 cells (DE3) (hsdS gal (λcIts857 ind1 Sam7 nin5 lacUV5-T7 
gene 1) (Studier and Moffatt, 1986) were used only once for the overexpression of 
His-p17.  These cells were maintained in the same manner as the DH5α cells.  The 
recipe for making all of the above strains competent as well as the transformation 
protocol was carried out according to Sambrook et al. (1989).  
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2.2 Recombinant plasmid construction 
Table 2.1: Description of the plasmids used in this study 
Plasmids Genotype/description Phenotype Reference 
pGEM-T Easy Cloning vector (T7 SP6 promoter) ampR Promega 
pCW56 Insect expression vector containing 
the eGFP CDS flanked by 5’BamH1 
and 3’NotI restriction sites 
(hr:AcMNPV promoter) 
ampR, kanR Walter, 2008 
pMV2 Vector containing N-terminal 6x His 
HaSV p17 CDS 
ampR Vlok, 2009 
pMV18 Insect expression vector (pCW56 
backbone) with HaSV RNA 2 cDNA 
sequence inserted using 5’BamH1 
and 3’SexA1 (hr:AcMNPV promoter) 
ampR, kanR Vlok, 2009 
pAM8 pGEM-T Easy containing 5’UTR of 
HaSV RNA 2 and p17 CDS flanked 
by 5’HindIII and 3’BglII  sites (T7 
promoter) 
ampR This study 
pAM9 pAM8 sequence with a mutation to 
the start codon of the p17 CDS to an 
EcoRV site, silencing the gene (ATG 
AGC – GAT ATC)  
ampR This study 
pAM10 Insect expression vector (pMV18 
backbone) with mutated HaSV RNA 2 
cDNA sequence from pAM9 in which 
the p17 CDS has been silenced 
(hr:AcMNPV promoter) 
ampR, kanR This study 
pFastBac 
Dual 
Baculovirus donor plasmid (AcMNPV 
bacmid with both polH and p10 
promoters) 
ampR, gentR Invitrogen 
pAM20 Baculovirus donor plasmid (pFastBac 
Dual backbone) with HaSV RNA 2 
sequence (from pMV18) inserted into 
the p10 cloning cassette between 5’ 
SmaI and 3’ NsiI sites 
ampR, gentR This study 
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Plasmids Genotype/description Phenotype Reference 
pAM21 Baculovirus donor plasmid (pFasBac 
Dual backbone) with mutated HaSV 
RNA 2 sequence (from pAM10) 
inserted into the p10 cloning cassette 
between 5’ SmaI and 3’ NsiI sites 
ampR, gentR This study 
pAM12 pGEM-T Easy containing the p17 
CDS PCR amplified from pMV18 
(using primers AM13F and AM14R) 
ampR This study 
pAM22 Baculovirus donor plasmid (pFasBac 
Dual backbone) with p17 CDS (from 
pAM12) inserted into the polH cloning 
cassette between 5’BamHI and 3’PstI 
sites 
ampR, gentR This study 
 
pAM23 
Baculovirus donor plasmid (pFasBac 
Dual backbone) with HaSV RNA 2 
sequence (from pAM20) in the p10 
cassette and the p17 CDS (from 
pAM22) in the polH cassette  
 
ampR, gentR 
 
This study 
pAM24 Baculovirus donor plasmid (pFasBac 
Dual backbone) with mutated HaSV 
RNA 2 sequence (from pAM21) in the 
p10 cassette and the p17 CDS (from 
pAM22) in the polH cassette 
ampR, gentR This study 
pMT20F pGEM-T Easy containing HaSV VCap 
(p71) CDS (T7 and SP6 promoter) 
LEU2, 
ampR 
Tomasicchio 
et al. 2007 
pAM26 polHF pGEM-T Easy containing a fragment 
of the polH promoter and cloning 
cassette from pFastBac Dual (cloned 
via PCR amplification using primers 
AM18polH and JRS 61) 
ampR This study 
eGFP – enhanced green fluorescence protein; hrAcMNPV – hybrid insect promoter 
from the Autographica californica multicapsid nuclear polyhedrosis virus; UTR – 
untranslated region; CDS – coding sequence; ampR – ampicillin resistance (100 
µg/µl); kanR – kanamycin resistance (50 µg/µl); gentR – gentamycin resistance (7 
µg/µl). 
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Construction of pAM10 
A schematic representation of the cloning strategy used for the construction of the 
plasmid pAM10, in which the AUG start codon of the p17 ORF is mutated to an 
EcoRV restriction site, is shown in Fig. 2.1.  pAM10 was derived from pMV18, a 
construct developed by M. Vlok (Vlok, 2009).  This construct contains the wild type 
HaSV RNA 2 cDNA sequence under the control of the hybrid promoter from the 
Autographa californica multicapsid nuclear polyhedrosis virus (hr:AcMNPV, which is 
transcriptionally active in S. frugiperda Sf9 cells).  In this construct, HaSV RNA 2 is 
flanked precisely at its 3’ end by the hairpin cassette (HC) ribozyme followed by the 
Simian Virus 40 (SV40) origin of replication and an ampicillin resistance selectable 
marker (ampR).  A 719bp fragment from HindIII to BglII of pMV18, which included the 
full p17 coding sequence, was amplified using primers AM7F 
(AACAACCAAGCTTAATCGAATTCCG) and AM8R (AGATCTCTCTTATCTCT 
GCGTCGACGGA).  The PCR was carried out using the Expand High Fidelity PCR 
system (Roche), the amplification product gel-purified using the Zymoclean Gel DNA 
Recovery kit (Zymo Research) and then ligated into the pGEM-T Easy vector.  The 
resulting plasmid, pAM8, was transformed into competent DH5α cells using the 
methods of Sambrook et al. (1989).  MacConkey agar plates containing ampicillin 
(100 µg/µl) were used to screen for recombinant clones.  Colonies potentially 
containing the plasmid of interest were picked and inoculated into LB broth 
containing ampicillin (100 µg/µl) and allowed to grow at 37 °C overnight.  Plasmid 
DNA was then extracted using the “Easyprep” method developed by Berghammer 
and Auer, (1993), and digested with EcoRI as a diagnostic test since this enzyme 
releases inserts from the vector DNA.  pAM8 DNA was isolated using the High Pure 
Plasmid Isolation Kit (Roche) and digested with relevant endonucleases to confirm 
the identity of the new plasmid.  The fidelity of the sequence was further confirmed 
by Sanger sequencing. 
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Figure 2.1: Cloning strategy for the construction of pAM10.  pAM10 contains an 
exact full length HaSV RNA 2 cDNA sequence (as in pMV18) but for a mutation to 
the p17 start codon and thus will not express p17.  A precise 3’UTR is ensured due 
to the HC ribozyme sequence.  A more detailed explanation of the process as well 
as the characteristics of each vector is outlined in the paragraph above. 
 
Plasmid pAM8 was subjected to site-directed mutagenesis (SDM) using pfu DNA 
polymerase (Promega) and primers AM9SDM (CAGCGTTGATAGCG 
CCGATTGATATCGAGCACACCATCGCCCAC) and AM10SDM (GTGGGCGAT 
GGTGTGCTCGATATCAAATCCGCGCTATCAACGCTG) such that the first and 
second codons of the p17 ORF (ATG AGC) were mutated to an EcoRV restriction 
endonuclease site (GAT ATC), which served as a diagnostic test for the mutant 
plasmid, pAM9.  Following digestion with DpnI to remove template DNA, a HindIII to 
BglII fragment carrying the mutated p17 ORF was excised from pAM9 and inserted 
into pMV18 to create pAM10, which carries the full HaSV RNA2 sequence with the 
AUG start codon of p17 mutated to GAT to prevent expression of p17.     
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Construction of recombinant pFastBac Dual transfer vectors 
pFastBac Dual was used as the transfer/donor vector for the development of 
recombinant baculoviruses according to the Bac-to-Bac Baculovirus Expression 
System (Invitrogen).  The transfer plasmids pAM20 (Fig. 2.2 A) and pAM23 (Fig. 2.2 
B), derived from pMV18 carry the wild type HaSV RNA 2 cDNA sequence 
expressing p17 and VCap (p71), the virus capsid protein precursor, while pAM21 
(Fig. 2.2 C) and pAM24 (Fig. 2.2 D) are derived from pAM10, in which the p17 start 
has been mutated and thus express only VCap off RNA 2.  Both pAM23 and pAM24 
contain a functional p17 ORF on a separate promoter (polH) and thus will express 
p17 regardless of the mutation state of RNA 2. 
 
To construct pAM20 and pAM21, plasmids pMV18 and pAM10 were digested with 
SmaI and NsiI and the resulting fragment of 2628 bp, which encompasses the full 
length HaSV RNA2 cDNA sequence (wild type or mutated) with the HC ribozyme at 
its 3’ end, was gel-purified and cloned into the same sites on the pFastBac Dual 
vector, downstream the p10 promoter.  pAM20 is thus analogous to pMV18 and 
pAM21 to pAM10. 
 
Constructs pAM23 and pAM24 are derivatives of pAM20 and pAM21 respectively, 
and carry the p17 ORF downstream of the polH promoter on pFastBac Dual (Fig. 
2.2).  The plasmid pAM12 contains the p17 ORF, generated by cloning a PCR 
product from pMV18 using primers AM13F (AGATCTATGAGCGA 
GCACACCATCGCC) and AM14R (CTGCAGTT ATCTCTGCGTCGACGGAGAACT).  
The p17 ORF was subcloned into pFastBac Dual (Invitrogen) using the restriction 
sites liberated by PstI and BglII.  The resulting intermediate vector, pAM22, was 
screened using SpHI and represents a baculoviral transfer vector containing only the 
p17 ORF under the control of the polH promoter. pAM23 and pAM24 were 
constructed by digesting pAM20 (producing the insert for pAM23) and pAM21 
(producing the insert for pAM24) with SmaI and NsiI and each fragment was ligated 
into the corresponding sites on pAM22.   
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A 
pAM20
7832 bp
Polh
p10
p17
p71
HSV tk PolyA
SV40 PolyA
Tn7L
Tn7R
F1Intergenic region
HC Ribozyme
HaSV RNA2
Ampr
Gmr
EcoRV (2899)
Nsi I (4265)
Sma I (6889)
EcoRI (6262)
EcoRI (7 196)
 
B 
pAM23
8232 bp
p71
p17
p17
p10
Polh
HaSV RNA2
HC Ribozyme
F1Intergenic region
Tn7R
Tn7L
SV40 PolyA
HSV tk PolyA
Ampr
Gmr
Nsi I (4265)
Sma I (6889)
 
C 
pAM21
7832 bp
Polh
p10
p71
HSV tk PolyA
SV40 PolyA
Tn7L
Tn7R
F1Intergenic region
Mutated HaSV RNA2
HC Ribozyme
Mutated AUG-EcoRV
Ampr
Gmr
Nsi I (4292)
Sma I (6916)
EcoRI (6289)
EcoRI (7 223)
EcoRV (2926)
EcoRV (65 99)
 
D 
pAM24
8207  bp
p17
p10
Polh
p71
F1Intergenic region
Tn7R
Tn7L
SV40 PolyA
HSV tk PolyA
Mutated AUG-EcoRV
HC Ribozyme
Mutated HaSV RNA2
Ampr
Gmr
Nsi I (4265)
Sma I (6864)
EcoRV (2899)
EcoRV (65 7 2)
 
 
Figure 2.2: Recombinant baculovirus transfer/donor vectors used in this study.  
The vectors in this diagram were constructed by cloning into the pFastBac Dual 
backbone and consequentially contain all the essential features for the development 
of a recombinant baculovirus, i.e. Tn7L and Tn7R transpositional elements and two 
selectable markers the gentamycin (Gmr) and ampicillin (Ampr) resistance genes.  
The pFast-Bac Dual system allows for the expression of two sets of genes by one 
virus via the dual promoters, p10 and polH.  pAM20 (A) and pAM21 (C) contain 
HaSV RNA 2 cDNA under the transcriptional control of the p10 promoter flanked 
precisely by the HC ribozyme (3’ end).  Both p17 and VCap (p71) will be expressed 
from pAM20, while only VCap (p71) will be expressed from pAM21.  pAM23 (B) was 
derived from pAM20 but will express another copy of p17 from the polH promoter as 
well.  pAM24 (D) was derived from pAM21 and will only express p17 from polH.     
 
The plasmids pAM23 and pAM24 contain HaSV RNA2 cDNA under the control of the 
p10 promoter in one direction and the p17 ORF under the control of the polH 
promoter in the other direction (Fig. 2.2).  pAM24 differs from pAM23 in the same 
manner as pAM21 differs from pAM20, in that the p17 ORF is silenced on the RNA 2 
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cDNA sequence.  The integrity of the viral cDNA in each of the constructs used for 
generating recombinant baculoviruses was confirmed by Sanger sequencing. 
 
2.3 Construction of recombinant baculoviruses (Bac20, Bac21, 
Bac23 and Bac24) 
Construction of recombinant bacmids  
Plasmid transfer constructs pAM20, pAM21, pAM23 and pAM24 were transformed 
into DH10Bac cells according to the methods described in the Bac-to-Bac 
Baculovirus Expression System manual (Invitrogen).  Blue white screening 
(facilitated by adding X-Gal and IPTG to the LA Bac plates) was carried out by 
spreading each transformation reaction onto LA Bac plates and allowing the cells to 
grow at 37 °C for 24 – 48 hours.  White colonies, which represented the successful 
transposition of the recombinant DNA from the transfer vector into the genomic 
baculoviral DNA, were picked and incubated into LA containing the relevant 
antibiotics and allowed to grow overnight at 37 °C.  In order to confirm that the 
colonies where “true whites” the liquid culture was re-streaked using the 3-way 
streak technique.  After confirmation of the phenotype, the ZR Bac DNA Miniprep kit 
(Zymo Research) was used to isolate the recombinant baculoviral genome, referred 
to as a bacmid.  The bacmids and thus the subsequent recombinant baculovirus that 
would be generated from each bacmid were designated Bac20, Bac21, Bac23 and 
Bac24; after the plasmid transfer vectors from which they were derived. 
 
PCR analysis was carried out using KAPA Taq ReadyMix DNA polymerase (KAPA 
Biosystems) to verify the recombinant bacmid DNA.  Due to the size of the 
recombinant sequence inserted into the bacmids, five separate reactions with 
different primer pairs were used to verify the fidelity of each bacmid.  The primer 
pairs used were as follows: (1) M13F (CCCAGTCACGACGTTGTAAAACG) and 
M13R (AGCGGATAACAATTTCACACAGG); (2) M13F and 60F (CCCCGCC 
ACTGACAACTTC); (3) AM14R (CTGCAGTTATCTCTGCGTCGACGGAGAACT) 
and M13R; (4) AM18polH (ATTCATACCGTCCCACCATCGGG) and AM14R; (5) 
JRS56 (GTCGTTGGGAGTTTCGTCCG) and JRS57 
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(CGGTTCTGAACATCGGAAAGG) (the binding sites for each primer are 
represented schematically in Fig. 2.3).  A more detailed description of these as well 
as the other primers used in this study is provided in Appendix 1.  The conditions for 
the PCR reactions are presented in Appendix 2.  Each amplicon that resulted from 
the amplification between JRS56 and JRS57 was also subjected to digestion with 
EcoRV to verify the presence of the mutation in Bac21 and Bac24. 
 
 
 
Figure 2.3: Schematic representation of primer binding sites on the 
recombinant bacmids.  The recombinant region between the Tn7R and Tn7L (blue 
arrows) transposons was transferred into the bacmid and PCR used to verify the 
recombinant genes.  Different primer pairs were used to span the length of the HaSV 
RNA 2 cDNA.  The sequence of each primer and which primers were used together 
are mentioned in the paragraph above.  The approximate region of each binding site 
is represented in the figure.  Black arrows – promoters p10 and polH, orange arrows 
– recombinant HaSV genes (VCap [p71] and p17) and the curved arrow above the 
blue line – HC ribozyme. 
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Transfection of Sf9 cells with recombinant bacmid DNA 
The Sf9 cell line was maintained in TC100 complete insect growth medium 
(Cambrex) containing 10 % foetal bovine serum (v/v), and 1 % 
penicillin/streptomycin (v/v) at 28 °C.  For bacmid transfections, approximately 8 x105 
cells were seeded into each well of a six-well plate, in 2 ml TC100 complete insect 
medium.  The cells were evenly dispersed across the surface of the well by gentle 
agitation and left to settle.  Approximately 0.8 µg of recombinant Bac20, Bac21, 
Bac23 and Bac24 bacmid DNA was added to 12 µl of Fugene HD (Roche) 
transfection reagent made up to 200 µl with serum-free TC100 medium and 
incubated at room temperature for 30 minutes.  The Fugene:DNA complex was then 
added dropwise to the cells which were left at 28 °C for 15 minutes.  Next, 200 µl of 
serum-free medium was added and the cells incubated at 28 oC for 45 minutes, 
followed by the addition of a further 600 µl of medium and a further 2 hours’ 
incubation.  Finally 1.5 ml medium was added and the cells incubated for 3 days at 
28 °C.  Recombinant baculoviruses were harvested from the cells by removing the 
spent medium after the 3 days.  This represented the primary baculovirus stock for 
each virus (designated Passage #1).      
 
Infection of Sf9 cells with recombinant baculovirus and plaque purification. 
Approximately 8 x105 Sf9 cells was seeded into each well of a six-well plate and 
after the cells had settled the medium was removed.  Next 500 µl of Passage #1 
baculovirus was added to each well.  The cells were then incubated at 28 °C with 
very gentle agitation (55 rpm) for 1 hour and 2.6 ml of fresh TC100 complete medium 
subsequently added.  The cells were then incubated at 28 °C for 4 days. 
 
The supernatant extracted from each well (Passage #2) was used in to purify 
recombinant baculovirus from potential wild type contamination.  A six well plate was 
prepared containing 8.5 x105 cells per well.  A ten-fold dilution series was prepared 
for each virus from 10-1 to 10-6, to a final volume of 500 µl in Grace’s complete insect 
medium (Gibco).  Each dilution was dispensed per well of the plate and the cells 
incubated with gentle agitation (55 rpm) for 1 hour at 28 °C.  After incubation, the 
medium containing the baculovirus was removed from the wells and 2 ml of a 1:1 
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mixture of molten agarose (2 % v/v) and Graces’s complete medium (2 x v/v), 
warmed to 40 °C in order to maintain the agarose as a liquid, was carefully added to 
each well.  Once the agarose had set, the cells were incubated at 28 °C for 6 days 
after which 500 µl thiazolyl blue tetrazolium bromide stain (Sigma) (0.1 % v/v in 
phosphate buffered saline solution) was added to each well and left overnight to 
visualize viable vs lysed cells. 
 
Plaques were identified as circular zones where cell death had occurred and thus 
appeared lighter in colour compared to the healthy stained cells.  Virus present in 
plaques that were well distanced from any others and distinctive in size was 
removed using a 1 ml pipette tip and mixed into 500 µl TC100 complete medium.  At 
least 3 plaques were picked per baculovirus and 8 x105 cells subsequently infected 
with each plaque virus suspension, in the same manner as before.  After 3 days, the 
cells were examined for the presence of recombinant protein using SDS-PAGE and 
western blot analysis.  The resulting supernatant was set aside and represented 
Passage #3 of each baculovirus. 
 
Determination of viral titre and optimization of protein expression 
A single baculovirus was selected from those purified by plaque purification and a 
T25 flask of Sf9 cells was infected with 500 ul of the Passage #3 virus stock in order 
to increase the volume of recombinant virus.  The passaging procedure involved the 
same infection procedure as was carried out before, except that 4.5 x105 cells was 
infected and the total volume of virus added to the cells was increased to 2 ml.  After 
4 days incubation at 28 °C, a total of 5 ml supernatant (Passage #4) baculovirus 
stock was removed and the titre of each recombinant baculovirus stock determined 
using the agarose overlay protocol described above with a ten-fold dilution series 
from 10-3 to 10-8.  The titre was defined as the number of plaque forming units (pfu) 
per milliliter of inoculum used per well (pfu/ml) and was calculated according to the 
following formula: 
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- Pfu/ml = [1/dilution factor of virus infecting the well] x [number of plaques 
counted in the well] x [1/ml of baculovirus stock used per well]   
The virus titre was then used to calculate the optimal ratio of infectious virus particles 
to cells being infected, otherwise known as the multiplicity of infection (MOI):  
-  MOI = pfu/ml divided by the number of cells to be infected. 
Titres of between 5 x107 and 1 x108 were routinely obtained. 
 
Protein expression was optimized using expression of VCap (p71) as an indication to 
the potential of the baculovirus to produce HaSV VLPs.  Two parameters affecting 
protein expression were optimized, namely the MOI of the recombinant virus and the 
time of incubation.  In the first instance, 2 x106 cells per well of a six well plate were 
infected at a MOI of either: 0.1, 1.0, 2.0, 5.0 or 10.0 and incubated for 3 days at 28 
°C.  The cells were harvested and subjected to SDS-PAGE and western blot 
analysis using anti-VCap antibodies.  The lowest MOI that produced the highest 
amount of VCap was chosen and used to infect cells, which were then incubated for 
either 2 – 5 days.  These cells were also harvested and subjected to SDS-PAGE and 
western blot analysis to determine the optimum time of incubation for maximum 
expression levels.   
 
2.4 SDS-PAGE and western blot analysis 
Total cellular protein from baculovirus-infected cells was analysed by harvesting the 
cells in the following manner.  First the cells were resuspended in the spent medium 
and pelleted by centrifugation at 4000 xg for 5 mins.  After each point at which 
baculovirus had been passage through cells, the supernatant was set aside as a 
new baculovirus stock.  The pelleted cells were washed with 100 µl 50 mM sodium 
acetate, 250 mM NaCl, 5 mM Na2EDTA (pH 5.0) buffer and pelleted again at 5500 
xg for 5 minutes.  The final pellet was then resuspended in 100 µl of the sodium 
acetate buffer mentioned above with 100 µl 2 x SDS-PAGE sample buffer (12.5 % 
1M Tris pH 7.6, 0.04 % SDS, 10 % β-merchaptoethanol, 10 % glycerol and 0.01 % 
bromophenol blue).  Purified VLPs were mixed directly with an equivalent volume of 
2 x sample buffer.  All the samples were boiled for 5 minutes prior to loading and 
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SDS-PAGE carried out as per the protocol of Laemmli, (1970), using either 10 % (for 
the detection of VCap) or 15 % (for the detection of p17) resolving gels.  Proteins 
were either stained with Coomassie Briliant Blue (Sigma) or subjected to western 
blot analysis using the BM Chemiluminescence western blotting kit (Mouse/Rabbit) 
(Roche).  VCap was detected with rabbit polyclonal anti-VCap antibodies at a dilution 
of 1:10000 (diluted in 1 % bovine serum albumin (BSA) in TBS Tween buffer [10 % 1 
M Tris pH 7.6, 3 % 5 M NaCl and 0.1 % TBS Tween-20)] or rabbit polyclonal anti-
p17 antibodies at a dilution 1:25000 (also diluted in the 1 % BSA TBS Tween 
solution).  The procedure was carried out according to the methods of Towbin et al. 
(1979). 
 
2.5 Infection of Sf9 cells and VLP purification 
Approximately 1.4 x107 Sf9 cells were placed in each of two T75 flasks which were 
infected with either of the recombinant baculoviruses Bac20, Bac21, Bac23 and 
Bac24 at a MOI of 5.  An additional virus, designated VCAP, was also included in 
this experiment.  This baculovirus was developed and optimized in the laboratory of 
Prof. Jack Johnson at the Scripps Research Institute and was kindly supplied for 
experimentation (Taylor, 2003).     After 4 days, a modified protocol adapted from 
Taylor et al. (2002) and Bothner et al. (2005) was used to purify VLPs from the 
baculovirus-infected insect cells.  Zero point five percent NP-40 (v/v) was added 
directly to each flask and left to shake on ice for 15 minutes.  After shaking, cellular 
debris was pelleted by centrifugation at 10000 xg for 20 minutes at 4 °C.  The VLPs 
were pelleted through a 30 % sucrose cushion (w/v) prepared in 50 mM sodium 
acetate, 250 mM NaCl, 5 mM EDTA (pH 5) by ultracentrifugation at 100 000 xg for 4 
hours at 4 °C.  The resulting VLP pellets were resuspended overnight at 4 °C in 
approximately 100 µl of the sodium acetate buffer.  The following day VLPs were 
subjected to sucrose gradient ultracentrifugation (10 – 40 % w/v) for 1 hour and 30 
minutes at 140 000 xg.  The gradient was prepared using a Biocomp gradient maker 
107 ip.  The VLP band was subsequently extracted using a syringe and needle.  The 
VLPs were then concentrated by a final ultracentrifugation step at 140 000 xg for 4 
hours at 4 °C, ensuring that the tubes were filled to the brim (11 ml) by the addition 
of the sodium acetate buffer.  The resulting pellets were resuspended in 100 µl of the 
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sodium acetate buffer and either subjected to SDS-PAGE and western blot analysis 
or used for RNA extractions.   
 
2.6 Purification of wild type HaSV from infected Helicoverpa 
armigera insects 
Wild type HaSV was purified from infected Helicoverpa armigera insects according to 
the protocol described in the masters thesis of Vlok, (2009).  Essentially the only 
difference between extracting the wild type virus from the insects and extracting 
VLPs from the cells (described above) is the homogenization of the infected 
Helicoverpa armigera larvae.  H. armigera larvae previously infected with HaSV and 
stored at -80 °C were allowed to thaw on ice and then homogenized in approximately 
200 ml of 50 mM Tris-Cl (pH 7.4) per 100 g of infected larvae using a hand held 
blender.  The homogenization was then filtered through cheesecloth.  The wild type 
virus suspension was then subjected to the same series of centrifugation and 
ultracentrifugation steps as has been described for the extraction of VLPs.  The 
resulting pellets were resuspended in 100 µl of 50 mM sodium acetate, 250 mM 
NaCl, 5 mM EDTA (pH 5) buffer and either subjected to SDS-PAGE and western blot 
analysis or used for RNA extractions.       
 
2.7 Overexpression and affinity purification of 6x His-p17 in E. 
coli 
The vector pMV2 (Vlok, 2009) was used to express p17 with an N-terminal 6x His 
tag, in E. coli BL21 (DE3) cells.  E. coli BL21 (DE3) cells were transformed with the 
plasmid and single colonies inoculated into 5 ml of LB broth with ampicillin 
(100µg/µl).  The cells were left to grow overnight with agitation (200 rpm) at 37 °C.  
Two sets of 5 ml overnight cultures were inoculated into 100 ml LB broth with 
ampicillin (100 µg/µl) in 500 ml Erlenmeyer flasks.  The flasks were incubated at 37 
°C with agitation (200 rpm) until the OD600 nm reading reached 0.4 – 0.6 nm.  
Expression of p17 was induced in one of the two flasks by the addition of 1 mM 
Isopropyl β-D-1 thiogalactopyranoside (IPTG) while the other was left uninduced as 
a control.  One milliliter samples were taken at time zero and every 2 hours for a total 
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4 hours.  Both induced and uninduced samples were analysed via SDS-PAGE and 
western blot to detect expression of p17. 
 
In order to produce larger quantities of p17, 500 ml of the LB-Amp broth was 
inoculated with 50 ml pMV2 transformed BL21 culture.  After 4 hours the cells were 
harvested from the broth via centrifugation at 2500 xg for 10 mins.  The pellets were 
stored at -80 °C or resuspended in 200 µl sonication buffer.   
 
His-p17 purification involved the sonication of the cells on ice for 10 second intervals 
for 5 mins at 45 Hertz.  The cellular debris was then pelleted at 10000 xg for 20 mins 
at 4 °C.  The His-Spin Protein Miniprep (Zymo Research) kit was used to purify the 
His-p17 from the supernatant according to the manufacturers’ instructions.  The 
protein was resuspended in 150 µl of the His-elution buffer and 5 µl tested via SDS-
PAGE.  To the rest of the sample 150 µl 2 x SDS-PAGE sample buffer was added 
and split into three 50 µl aliquots.  Aliquots were stored at -20 °C until used.  
 
2.8 Analysis of RNA packaged into VLPs 
RNA extraction and denaturing gel electrophoresis 
Where possible, all materials used during RNA experimentation were double-baked 
at 200 °C or in the case of autopipettes, tips and other disposables, treated with a 
combination of household bleach and RNAse Away (Molecular Bioproducts).  Total 
cellular RNA was extracted from 2 x106 Bac20, Bac21, Bac23, Bac24 and VCAP 
infected and uninfected Sf9 cells using the Quick-RNA MiniPrep kit (Zymo Research) 
according to the manufacturers’ instructions.  The RNA was resuspended in 40 µl 
RNAse-free tripled distilled water (dddwater).  The total 100 µl of the VLP 
preparation extracted from the Sf9 cells as well as an equivalent concentration of 
wild type HaSV was used for RNA extraction.  The RNA contained in the VLPs as 
well as the wild type virus was extracted using the phenol/chloroform method of 
Walter, (2008).  The RNA pellet from each VLP or wild type virus isolation was also 
resuspended in 40 µl RNAse-free dddwater and left to resuspend for approximately 1 
hour at 4 °C.   
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Prior to northern blotting, RNA was analysed using formaldehyde denaturing 
agarose gel electrophoresis in 4-Morpholine-propane sulfonic acid (MOPS) buffer 
(200 mM MOPS, 50 mM sodium acetate, 10 mM EDTA, pH 7.0 with sodium 
hydroxide) according to the methods described in Sambrook et al. (1989).  Prior to 
loading, 2 x RNA loading dye which also contained ethidium bromide (Fermentas) 
was added to each RNA sample and heated at 70 °C for 10 minutes.  Two 
microlitres of the RiboRuler High Range Ladder (Fermentas) was treated in the 
same manner and electrophoresed beside the samples.  RNA was visualised on a 
UV transilluminator and imaged using the Uviprochemi (Uvitech) program. 
 
In vitro transcription labeling of RNA probes 
Two probes were generated for northern blot analysis.  The first was used to detect 
HaSV RNA 2 transcripts and was synthesized in vitro from pMT20F, a plasmid 
constructed by M. Tomassicchio (Tomasicchio et al., 2007).  This plasmid contains 
the VCap ORF flanked by SP6 and T7 promoters.  The second probe was designed 
to detect baculoviral RNA transcripts expressed from the polH promoter using the 
vector pAM26 polHF.  This construct was derived by PCR amplification of the cloning 
cassette down-stream the polH promoter on the native pFastBac Dual vector using 
primers AM18polH (ATTCATACCGTCCCACCATCGGG) and JRS61 
(CTCTAGTACTTCTCGACAAGCTTGTCGAG).  The resulting fragment was cloned 
into pGEM-T Easy resulting in pAM26 polHF.   
 
For in vitro transcription reactions, both plasmids were digested with NcoI and the 
linearised DNA purified using the Zymo DNA Clean and Concentrator Kit (Zymo 
research).  The probes were synthesized by transcription with SP6 RNA polymerase 
(Roche) and labeled in vitro using the DIG High Prime DNA labeling and Detection 
Starter Kit (Roche).  The reaction was incubated at 42 °C for 1 hour after which 2 µl 
RNAse-free DNAse (Roche) was added and the mixture placed at 37 °C.  After 
allowing 15 minutes for DNA digestion, the reaction was stopped by the addition of 2 
µl 0.2 M Na2EDTA (pH 8.0).  The quality of the probes was determined by analysis 
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on a 1 % non-denaturing agarose gel and the RNA visualized in the same manner as 
before.  If not used immediately, the probes were stored in aliquots at -80 °C.     
 
Northern blot analysis 
Northern blots were carried out by transferring the RNA from a denaturing agarose 
gel onto a nitrocellulose membrane (Amersham Biosciences) according to Schneider 
et al. (1994) and fixed to the membrane by UV-irradiation for 5 minutes.  Following 
the transfer and fixing of the RNA to the membrane, it was pre-hybridised in 15 ml 
DIG Easy Hyb Buffer (Roche) at 68 °C for 30 minutes.  During this time, one 
microgram of either of the probes was added to 50 µl of RNAse-free dddwater and 
heated to 65 °C for 5 minutes, after which the probe was placed on ice.  The RNA 
probe was then further diluted by adding the full volume (55 µl) to approximately 10 
ml pre-warmed (68 °C) DIG Easy Hyb Buffer (Roche).  After the 30 min pre-
hybridisatioin period had elapsed, the DIG-labeled probe/hybridisation buffer solution 
replaced the buffer that was washing over the membrane and the probe was left to 
hybridise to the RNA for approximately 16 hours with rotation.  After hybridisation, 
the membrane was washed twice with 50 ml low stringency buffer (2 x SSC, 0.1 % 
SDS) at room temperature with gentle rocking for 5 minutes.  These washes were 
followed by two 15 minute washes with 50 ml pre-warmed high stringency buffer (0.1 
x SSC, 0.1 % SDS) at 68 °C in the oven.  DIG-labeled RNA targets were visualised 
using the CSPD Chemiluminescent assay as per the instructions of the DIG High 
Prime DNA labeling and Detection Starter Kit (Roche). 
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Chapter 3 
Results 
 
3.1 Introduction 
The plasmid expression system improved the understanding of tetravirus packaging 
by elucidating some of the features that were essential for the specific packaging of 
RNA 2 by VLPs (Vlok, 2009).  Using the plasmids depicted in Fig. 3.1. the Vlok study 
showed that neither deletions of the 5’ UTR preceding the p17 ORF (pMV20), the 3’ 
UTR after the VCap ORF (pMV27) or the deletion of both regions together (pMV28) 
had any effect on the packaging of RNA 2 by VLPs assembled in the plasmid 
transfected Sf9 cells. 
   
 
 
Figure 3.1: Schematic representation of the plasmids used in the study by Vlok 
(2009).  The construct pMV18 represents the wild type HaSV RNA 2 plasmid as both 
the 5’UTR (semi-precise) and 3’UTR (precise) are intact and p17 and p71 (VCap) 
are expresssed from the baculoviral insect promoter hr:AcMNPV.  Each plasmid 
represented by lines below pMV18 contains a deletion of the RNA 2 sequence 
depicted as a line-break: pMV20 (5’UTR deleted), pMV26 (5’UTR and the first 80 
nucleotides of p17 deleted), pMV27 (3’UTR deleted) and pMV28 (both 5’and 3’UTR’s 
deleted).  A precise 3’UTR is maintained by an HC ribozyme on each construct. 
 
The only plasmid that changed the RNA 2 packaging phenotype in the experiment 
was pMV26.  HaSV RNA 2 could not be detected in VLPs derived from the 
transfection of pMV26.  In this plasmid the first 80 base pairs of the p17 ORF (which 
do not overlap VCap) as well as the 5’UTR region had been deleted.  Therefore, 
pMV26 was the only plasmid depicted above in which p17 would not be expressed 
when transfected into the Sf9’s.  Since the 5’UTR deletion alone did not effect 
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packaging, it was concluded that either p17 itself was required for packaging or that 
the packaging signal was present in the sequence between the start of the p17 and 
VCap ORFs.  Unfortunately Marli’s experiments were not able to delineate between 
the requirement for an RNA signal alone or the requirement for the protein as well as 
a potential signal.  For this reason this experiment was repeated with a new 
construct in which the RNA sequence would be maintained but p17 expression 
abolished (pAM10). 
 
3.2 The effect of silencing p17 on the packaging of RNA 2 into 
VLPs using the plasmid expression system 
In order to determine whether translation of the p17 ORF is required for the 
packaging of HaSV RNA 2 by VLPs, SDM was employed to mutate the AUG start 
codon of the p17 ORF to GAU, which encodes aspartic acid and thus abrogates 
initiation of translation.  Therefore, by mutating the p17 AUG cDNA sequence, p17 
translation could be abolished with only two codons being affected in the 
corresponding RNA sequence (AUG AGC to GAU AUC). This would also serve to 
introduce a diagnostic EcoRV site while maintaining most of the RNA sequence but 
abolishing p17 translation.  The construct pAM10 was thus an exact copy of pMV18 
but for the mutation of the first two codons of the p17 ORF.  Both pAM10 and pMV18 
were transfected into each of 4 T75 flasks (approximately 5 x107 cells) and the VLPs 
purified using the methods described in chapter 2.  
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Figure 3.2: Analysis of VLPs purified from pMV18 and pAM10 transfected Sf9 
cells.  After transfection of each plasmid into Sf9 cells, VLPs were purified according 
to the protocol mentioned in chapter 2 and subjected to SDS PAGE (A) and western 
blot (B).  Lane 1 – Unstained protein molecular weight marker, lanes 2 and 5 – wild 
type HaSV, lanes 3 and 6 – pMV18 derived VLPs and lanes 4 and 7 – pAM10 
derived VLPs.  The molecular weight standards are indicated in kDa next to the 
SDS-PAGE gel.  The arrows next to the blot indicate the position of p71 (VCap) – the 
capsid protein precursor and p64 - the major capsid protein.  The presence of p64 is 
indicative of VLP formation.  Western analysis was carried out using anti-VCap 
antibodies at a 1 in 10 000 dilution. 
 
VLPs were prepared from Sf9 cells transfected with pMV18 (wild type HaSV RNA 2) 
and pAM10 (p17 AUG start mutated) by resuspending the pellets obtained after 
ultracentrifugation and then sending them through a sucrose cushion and subjecting 
them to SDS-PAGE and western analysis.  Two protein products migrating at 
approximately 64 kDa and 71 kDa, were observed on polyacrylamide gels stained 
with Coomassie brilliant blue (Fig. 3.2 A, lanes 3 and 4).  The 64 kDa band, which 
co-migrates with the wild type HaSV capsid protein, is likely the mature β capsid 
subunit, while the 71 kDa band, observed only in VLP samples, corresponds to the 
uncleaved, capsid protein precursor.  Western analysis with anti-VCap antibodies 
confirmed that the 64 kDa and 71 kDa proteins corresponded to viral p64 and VCap 
(Fig. 3.2 B, lanes 6 and 7).  The presence of p64 as the major band in the VLP 
samples indicated the presence of mature VLPs.  The p7/(γ) capsid protein was not 
detected.    
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Figure 3.3: RNA 2 packaging by VLPs assembled in cells expressing HaSV 
VCap and/or p17.  (A). Denaturing agarose gel stained with ethidium bromide. Lane 
1 – wild type HaSV RNA ; lane 2 – RNA extracted from pMV18-derived VLPs and 
lane 3 – RNA extracted from pAM10-derived VLPs.  The sizes of the RNA marker 
are indicated to the left of the image.  (B)  Northern analysis of RNA extracted from 
VLPs assembled in Sf9 cells transfected with pMV18 (Lane 5) and pAM10 (Lane 6) 
compared with RNA extracted from the wild type virus (Lane 4).  Arrows to the right 
indicate the position of transcripts detected with a probe for HaSV RNA 2.    
 
RNA was extracted from the purified VLPs as well an equivalent amount of wild type 
HaSV, via a phenol/chloroform protocol described in chapter 2.  Analysis of the 
extracted RNA by denaturing agarose gel electrophoresis showed no significant 
RNA bands corresponding to the expected size of an RNA 2 transcript (2500 bases) 
for pMV18 VLPs (Fig. 3.3 A, lane 2) or pAM10 VLPs (Fig. 3.3 A, lane 3), nor were 
the genomic RNAs from the wild type virus detected (Fig. 3.3 A, lane 1).  Northern 
analysis using a probe for HaSV RNA 2, detected the viral RNA 2 migrating at 
approximately 2300 bases (Fig. 3.3 B, lane 4).  Two RNA species were detected in 
VLPs derived from pMV18, one migrating at approximately the same size as wild 
type HaSV RNA 2 and a larger species migrating at approximately 3500 bases 
consistent with the size of mRNA 2 uncleaved by the HC ribozyme (Fig. 3.3 B, lane 
5).  The result is consistent with previous observations (Vlok, 2009).  The same 
packaging phenotype was not observed in VLPs that assembled in cells transfected 
with pAM10.  A very faint signal for both RNA species was detected as well as a 
large amount of degraded RNA (Fig. 3.3 B, lane 6).  Since equivalent quantities of 
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VLPs were used for extraction of RNA (Fig. 3.2 A, compare lanes 3 and 4 and Fig. 
3.2 B, compare lanes 6 and 7), the decrease in the amount of viral RNA detected in 
VLPs assembled from cells transfected with pAM10 may indicate that p17 
expression is required for RNA 2 packaging.   
 
The major problem with the plasmid-based experimental system was the inefficient 
expression of both p17 and VCap and the inability to purify sufficient quantities of 
VLPs to for example, reliably quantify the amount of RNA extracted from the VLPs 
used for northern analysis.  In addition, the low levels of expression prevented the 
detection of p17 in cell-free extracts, so the veracity of the mutation in pAM10 could 
not be confirmed.  Thus it was decided to develop an alternative expression system 
that would result in more efficient expression of p17 and VCap. 
 
3.3 Development of a recombinant baculovirus expression 
system for the expression of VCap (p71) and p17    
The high levels of protein expression traditionally ascribed to a baculovirus system 
are primarily achieved due to the fact that the researcher is taking advantage of the 
natural infectious cycle of the virus to express a heterologous protein (Van Oers, 
2011).  It was decided that baculoviral expression would be the best system upon 
which to improve the analysis of HaSV RNA packaging.  The baculovirus 
Autographica californica multicapsid nucleopolyhedrosis virus (AcMNPV) is the most 
widely used and commercially available baculovirus and it was decided that the Bac-
to-Bac baculovirus expression system (Invitrogen), which uses AcMNPV, would be 
the best way to utilise baculoviruses for the expression of HaSV proteins.  Not only 
has the Bac-to-Bac system been widely used but it provides the additional 
advantage that each baculovirus can be made to produce two sets of recombinant 
proteins.  This is because the transfer/transplacement vector upon which the entire 
set-up relies, pFastBac Dual, contains bi-direction cloning cassettes under the 
control of the p10 and polH (polyhedrin) promoters.  These promoters are 
transcriptionally highly active during late phase infection of the baculovirus and 
cloning into either cassette does not limit protein expression from the other.  Thus a 
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recombinant baculovirus developed with the Bac-to-Bac system can produce more 
than one foreign protein in an insect cell.   Flanking the cloning cassettes on this 
plasmid are Tn7 transposon sites which have also been engineered into the cloned 
baculoviral genome housed in specific DH10Bac E. coli cells, known as a bacmid.  
After transformation of the recombinant plasmid into the E. coli cells and the 
application of selection pressure, transposition of the region between the transposon 
sites of the plasmid into the bacmid occurs via homologous recombination.  This 
then represents a recombinant baculovirus genome which is infectious and able to 
produce recombinant baculovirus able to produce foreign proteins.   
 
Once recombinant baculoviruses have been developed, two more steps need to be 
completed before the large scale expression of heterologous proteins is ensured.  
Firstly, the recombinant nature of the viruses has to be validated which involves PCR 
and baculoviral plaque purification.  Secondly, once pure recombinant baculoviruses 
have been isolated, the optimum conditions for protein expression in the insect cells 
need to be determined.  From the point at which the recombinant pFastBac Dual 
clones have been developed to the point at which optimal expression of recombinant 
protein occurs, takes several months and this is one of the few drawbacks of using 
baculoviral expression systems. 
 
The main reason to utilise baculoviruses was, as has been mentioned, because of 
their reputed high levels of protein expression.  It was reasoned that the best way to 
take advantage of this, in terms of studying HaSV RNA 2 packaging, would be to 
repeat the VLP packaging protocol developed by Vlok (2009) and carried out in 
section 2 of this chapter, but with baculoviruses instead of plasmids.   
 
Construction and validation of recombinant bacmids 
The first two baculoviruses developed were Bac20, a baculovirus representative of 
pMV18 and Bac21, a baculovirus representative of pAM10 (Fig. 3.4 A and C).  The 
primary objective for repeating the packaging experiments with Bac20 and Bac21 
was that the baculoviruses would produce higher levels of HaSV mRNA and 
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therefore more protein, consequently more VLPs could be produced meaning more 
RNA for analysis.  Clearly the expectation was that packaging by the Bac20 and 
Bac21-VLPs would be consistent with the packaging by the pMV18 and pAM10-
VLPs. 
 
A 
Bac20 
 
 
B 
Bac23 
 
 
C 
Bac21 
 
 
D 
Bac24 
 
 
 
Figure 3.4: Schematic maps of the recombinant regions of the Bac20, Bac21, 
Bac23 and Bac24 bacmids developed in this study.  In each panel the HaSV 
recombinant ORF’s p71 (VCap) and p17 are depicted in orange arrows (5’ to 3’).  
The solitary blue line 3’ to the p71 ORF depicts the end of HaSV RNA 2 and the 
point at which cleavage occurs via the HC ribozyme.  Each of the baculoviruses 
contains a copy of wild type HaSV RNA 2 cDNA (A and B) or the mutated RNA 2 
cDNA (C and D) opposite the p10 promoter (blue arrow).  The mutation on the p17 
ORF is depicted as a red cross.  In addition Bac23 and Bac24 (B and D) house a 
second functional p17 ORF opposite the polH promoter (black arrow).  Arrows in 
green stripes represent the Tn7R and Tn7L transposon sites which are responsible 
for the transposition of the portion between the black dashed arrows from the 
pFastBac Dual vector into the bacmid.  The primer binding sites used to confirm the 
viability of the recombinant bacmids by PCR are depicted by arrows above the map 
and correspond to the primer pairs shown in Table 3.1.  Gmr – gentamycin 
resistance gene. 
 
As mentioned previously, the Bac-to-Bac system carries the advantage of being able 
to produce more than one foreign protein from one recombinant baculovirus.  This 
therefore, made it possible to ask another question of the p17-RNA packaging 
system.  If a functional p17 ORF was expressed side-by-side the RNA 2 of pMV18 
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and pAM10, what would the packaging of the VLPs look like?  This was the 
motivation behind the development of the third and fourth baculoviruses; Bac23 
(pMV18 plus p17) and Bac24 (pAM10 plus p17) (Fig. 3.4 B and D).  As the data in 
section 2 suggested that the expression of p17 may mediate the packaging of RNA 
2, it would be interesting to see whether or not the protein could still mediate 
packaging if expressed from another RNA strand (trans packaging) and if it could 
mediate the packaging of its own mRNA as well. 
 
Following construction of the relevant recombinant plasmids, transposition of the 
expression cassette and isolation of bacmid DNA, it was important to verify that each 
bacmid contained the correct HaSV RNA 2 sequences.  In order to do this, PCR 
analysis was employed with a combination of primers, which would be able to 
distinguish between the wild type AcMNPV bacmid and Bac20 and Bac21 on the one 
hand and Bac23 and Bac24 on the other.  A description of the strategy used for the 
verification of the baculoviruses by PCR is presented in Table 3.1. and the results of 
the corresponding PCRs in Fig. 3.5. 
 
According to the Bac-to-Bac system manual (Invitrogen), the primers M13F (pucF) 
and M13R (pucR), which correspond to regions on the AcMNPV bacmid 
approximately 128 (M13F) and 145 (M13R) bp from the site of transposition should 
be used to determine whether the insert has been transposed into the bacmid.  This 
primer set would produce a PCR product of 276 bp from the empty AcMNPV bacmid, 
while recombinant bacmids would produce a larger amplicon consisting of the 5298 
bp of vector sequence plus the sequence of the insert (Table 3.1).  Unfortunately, 
despite repeated attempts at optimisation of this reaction, no conclusive results were 
obtained when using the recombinant bacmids as template DNA.  For this reason no 
result for this primer pair is reported in Fig. 3.5.  It was believed that the problem in 
this regard was that the desired product was too big to be amplified using this 
protocol. 
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Table 3.1: Strategy for the validation of the recombinant bacmids by PCR 
PCR 
primer 
pair 
Primer binding sites  
Expected PCR product size (bp) 
AcMNPV Bac20 Bac21 Bac23 Bac24 
M13F 
and 
M13R 
M13F – AcMNPV bacmid 
  
M13R - AcMNPV bacmid  
 
273 5298 5298 5298 5298 
M13F 
and 60F 
M13F – AcMNPV bacmid  
60F – 3’ end p71 (Nt 2075 – 
2094) 
0 2327 2327 2327 2327 
AM14R 
and 
M13R 
AM14R – 3’end of p17 (Nt 757 
– 733) 
M13R - AcMNPV bacmid  
0 1328 1328 1328 1328 
polH and 
AM14R 
polH – polH promoter (Nt 103 
– 125) 
M13R - AcMNPV bacmid  
0 0 0 600 600 
JRS56 
and 
JRS57 
JRS 56 – 5’ HaSV UTR (Nt 
144 – 164) 
JRS57 – p71 (862 – 841) 
0 719 719 719 719 
AcMNPV – Bac-to-Bac Autographica californica multicapsid nucleopolyhedrosis virus bacmid isolated 
and used in parallel with the recombinant bacmids; Nt – nucleotide; UTR – untranslated region; ORF 
– open reading frame.  
 
A 
M13F and 60F 
 
 
B 
AM14R and M13R 
 
 
C 
polH and AM14R 
 
 
D 
JRS56 and JRS57 
 
 
    
 
Figure 3.5:  PCR analysis of the four recombinant bacmids constructed for the 
expression of HaSV proteins.  Table 3.1 indicates the five sets of PCR reactions 
used to verify that Bac20 (lane 2), Bac21 (lane 3), Bac23 (lane 4) and Bac24 (lane 5) 
contained recombinant HaSV cDNA sequence.  Agarose gel analysis of the resulting 
PCR products is presented above with each primer pair indicated above each image.  
A non-recombinant AcMNPV bacmid was also included in the analysis (lane 1).  The 
size of the molecular weight marker is indicated to the left of (A) and the size of each 
amplicon indicated to the right of each picture in base pairs.  Predicted amplicons 
from each reaction are indicated by a white asterix. 
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To overcome this problem a further set of PCR reactions involving the M13 primers 
in conjunction with HaSV RNA 2 specific primers, which would produce shorter PCR 
products, was employed (Table 3.1).  As expected, PCR amplification with the 
AcMNPV bacmid as a template, using primers M13F and 60F, which binds in VCap, 
produced no amplicon (Fig. 3.5 A, lane 1).  In contrast a PCR product of 2327 bp 
was detected in the four recombinant bacmids, which is consistent with the presence 
of the RNA 2 sequence downstream of the p10 promoter (Fig. 3.5 A, lanes 2 – 5).  In 
the next PCR reaction, primers AM13R (which binds in p17) and M13R produced the 
expected amplicon of 1328 bp when only Bac20 was used as a template (Fig. 3.5 B, 
lane 2).  This reaction also resulted in other non-specific products of 1643 and 905 
bp.  When Bac21 was used as a template, using the same primers, only the 1643 bp 
band was visualised (Fig. 3.5 B, lane 3).  No amplicons for Bac23 and Bac24 were 
produced using the same reaction (Fig. 3.5 B, lanes 4 and 5).  There was no 
definitive reason why the Bac21 reaction did not produce the anticipated results, 
although it is interesting that a consistent non-specific product of 1643 bp was also 
observed.  With regards to the Bac23 and Bac24 reaction, it was postulated that the 
fact that there were two binding sites for the AM13R primer (two p17 ORFs in Bac23 
and Bac24) may have had an effect on the fidelity of the reaction.  This conclusion 
though remains to be proven.  The optimisation of this reaction will be required if it is 
going to be used for the validation of recombinant HaSV RNA 2 bacmids in the 
future, although it is was not necessary for this experiment, given the results of the 
remaining PCRs.  
 
To confirm that the p17 ORF was present downstream of the polH promoter on 
Bac23 and Bac24, a primer designed to bind in the polH promoter region (labelled 
polH) as well as a p17 specific primer, AM14R, was used (Fig. 3.5 C).  An expected 
PCR product of 600 bp was detected in the reactions with Bac23 and Bac24, while 
there was no corresponding PCR product in the reactions with Bac20 and Bac21 
(Fig. 3.5 C, lanes 4 and 5 vs. lanes 2 and 3).  A non-specific product of 1214 bp was 
observed in the AcMNPV lane (Fig. 3.5 C, lane 1).  Finally, a PCR using two RNA 2 
specific primers (JRS56 and JRS57) produced an expected 719 bp amplicon in 
reactions containing all four recombinant bacmids, which was absent in the wild type 
bacmid (Fig. 3.5 D, lanes 2 – 5).  Taken together the PCR analysis confirmed the 
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integrity of the recombinant bacmids and that they contained the correct HaSV RNA 
2 sequence.  One final element of verification was required to be absolutely sure of 
the nature of the four recombinant bacmids and that was the fidelity of the mutation 
on Bac21 and Bac24 carrying the mutant p17 ORF derived from pAM10.  
 
To confirm that Bac21 and Bac24 carried the mutant RNA2 sequence with the 
mutated start codon of p17, PCR products were generated using primers JRS56 and 
JRS57 (the product of which includes the p17 start site).  The PCR products were 
then digested with EcoRV and resolved by agarose gel electrophoresis. 
 
 
 
Figure 3.6: Restriction analysis of PCR products from JRS56 to JRS57 with 
EcoRV.  The agarose gel depicts the results of the EcoRV digestion of the 
amplicons produced by PCR of the recombinant bacmids with JRS56 and JRS57.  
Lane 1: AcMNPV bacmid DNA; lanes 2 – 5: Bac20 – 24 DNA. 
 
In contrast to Bac20 and Bac23, which remained undigested, EcoRV digestion of the 
PCR products derived from Bac21 and Bac24 produced restriction fragments of 
approximately 600 and 140 bp (Fig. 3.6, lanes 2 and 4 vs. Lanes 3 and 5).  In 
combination with the results from PCR analysis, this result confirms the presence of 
the correct HaSV RNA 2 sequences in the recombinant bacmids. 
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Production of recombinant baculovirus stocks 
Having confirmed the isolation and identity of each recombinant bacmid generated, 
the next step in the process was to generate recombinant virions.  Accordingly, Sf9 
cells were transfected with each recombinant bacmid and the supernatant used for a 
plaque assay to enable the isolation of individual recombinant baculovirus clones.  
For each virus, three plaques that were well defined and well separated from one 
another was purified.  Each plaque suspension was then used in one further round of 
infection to increase the virus titre (Passage #3).  Western blot analysis of whole cell 
extracts was used to confirm expression of VCap and thereafter one recombinant 
virus (from one of three plaques) was selected for each of the four baculoviruses for 
further studies. 
   
 
 
Figure 3.7: Western analysis of protein extracts from cells infected with 
purified recombinant baculoviruses, Bac20, Bac21, Bac23 and Bac24.  Whole 
cell extracts from the cells infected with purified recombinant plaqued viruses were 
resolved by SDS-PAGE and western analysis conducted with anti-VCap antibodies 
(1: 10000 dilution).  Lane 1 marked HaSV represents a wild type HaSV sample 
isolated from infected H. armigera larvae.  Lane 2 marked AcMNPV represents the 
whole cell extracts from a non-recombinant baculovirus vector that was isolated and 
infected in parallel with the recombinant baculoviruses. 
 
A protein migrating at approximately 71 kDa was detected in cell free extracts 
derived from Sf9 cells infected with recombinant viruses Bac20, Bac21, Bac23 and 
Bac24 (Fig. 3.7, lanes 3 – 6).  This protein was not expressed in Sf9 cells infected 
with the AcMNPV vector (Fig. 3.7, Lane 2).  The level of expression supported by 
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each of the baculoviruses was not equivalent, probably due to each virus stock 
having a different titre.  It is also important to note that protein expression by each 
virus was not yet optimised at this juncture.  In addition, the presence of p71 and 
little p64 as represented by the wild type HaSV particles (Fig. 3.7, lane 1) indicated 
that the VLPs had not matured at the time of protein analysis.  The selected 
recombinant virus isolates were used to seed fresh tissue culture cells and passaged 
to increase the virus titre. 
 
3.4 Optimisation of VCap (p71) and p17 expression by the 
recombinant baculoviruses  
There are three conditions that are directly responsible for the amount of protein a 
recombinant baculovirus will produce.  The first is the number of cells which are 
infected by the virus and the aim here is to have every cell infected.  According to the 
Bac-to-Bac system manual (Invitrogen) the optimal number of cells tends to range 
consistently between 8 – 9 x105 cells per well in a six well plate.  The second factor 
is the multiplicity of infection (MOI), which refers to the number of virions per cell.  
The aim is to determine at what MOI one would achieve the most efficient rate of 
infection given both the cell density and the titre of the inoculum being used.  This is 
therefore, determined by the number of cells in the dish and the concentration of the 
virus used in the infection.  The third factor that needs to be optimised is the time of 
expression.  In order to achieve optimal expression of a heterologous protein, the 
correct balance between the MOI and the time of expression needs to be determined 
and thus each of these two elements was independently optimised for the four 
recombinant baculoviruses. 
 
The determination of the titre of each of the recombinant virus stocks was calculated 
by using plaque assays and a formula described in chapter 2.  The titre for each 
stock varied from 6 x107 to 1.2 x108.  The specific titre of each of the recombinant 
baculoviruses was used to calculate the MOI for each virus to infect one well of a six 
well plate.  An MOI optimisation assay was carried out separately with each virus at 
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a MOI of 0.1, 1.0, 2.0, 5.0 and 10 in order to determine the most effective infection 
strategy.  The time of expression was kept constant at 3 days. 
 
A 
 
B 
 
 
Figure 3.8: MOI optimisation assay of VCap expression by recombinant 
baculoviruses.  Western analysis was carried out on cell free extracts after the cells 
were infected for 3 days with Bac20 and Bac21 (A) and Bac23 and Bac24 (B) at a 
MOI of between 0.1 and 10 using anti-VCap antibodies (1 in 10 000 dilution).  Lanes 
1 labelled HaSV signify a sample of wild type HaSV isolated from H. armigera larvae.  
The lanes labelled AcMNPV signify protein derived from cells infected with the 
baculovirus vector AcMNPV.  The size markers are presented to the left of each 
figure (in kDa) and bands believed to represent p71 (VCap) and p64 (β) by arrows to 
the right. 
     
Two major bands, migrating at 71 kDa and 64 kDa, were detected at each MOI used 
for infection in cell free extracts derived from Sf9 cells infected with Bac20, Bac21, 
Bac23 and Bac24 (Fig. 3.8, A and B).  The presence of p64 suggested the presence 
of mature virions despite the fact that the extracts were only briefly exposed to the 
low pH buffer which favours assembly.  Several additional smaller proteins were also 
detected in the extracts, which were attributed to VCap degradation products since 
they were not present in the cell-free extracts derived from cells infected with the wild 
type AcMNPV baculovirus (Fig. 3.8 Lanes 2, 5, 8, 11 and 14).  It could be argued 
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that given the over-expression by the baculoviruses, not all the VCap is assembled 
into provirions and, therefore, is degraded by cellular proteases.  Although p71 and 
p64 were present at each MOI tested, judging by the strength of the signal, western 
analysis revealed that a MOI of 5 or 10 was the most consistent MOI at which to 
infect all four recombinant viruses to produce high levels of p71.  Due to the limited 
quantities of baculovirus stock available, it was decided to work with a MOI of 5 to 
make VLPs.   
 
As mentioned before, the amount of time allowed for recombinant baculoviruses to 
infect the cells and subsequently express recombinant protein is also an important 
factor determining a high level expression strategy.  Accordingly, a time course 
assay was carried out with all four recombinant baculoviruses.  Since it had been 
concluded that a MOI of 5 was the most optimal level of infection for each virus, this 
element was kept constant while the time at which the protein extracts were 
collected was varied between 2 to 5 days.  Whole cell extracts from infected cells 
were resolved by SDS-PAGE and the presence of VCap detected by western blot 
using anti-VCap antibodies (Fig 3.9). 
 
Only a very slight and gradual increase in protein production was observed between 
2 – 5 days of expression as a function of the strength of the signals from the protein 
bands (Fig. 3.9, A and B).  The VCap degradation products observed during the MOI 
optimisation assay were also observed in this experiment.  Given the results of this 
assay, one could argue that the VLPs could be produced from each of the 
baculoviruses at a MOI of 5 following 2, 3, 4 or 5 days of expression.  An analysis of 
the literature illustrated that at a MOI of 5, the production of NωV VLPs was favoured 
at 4 days post-infection (Agrawal and Johnson, 1995; Taylor et al., 2002; Maree et 
al., 2005).  Thus it was decided to allow 4 days for maximum expression of VCap. 
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Figure 3.9: Time course assay of VCap expression by recombinant 
baculoviruses.  Western analysis to detect VCap in cells infected with (A) Bac20 
and Bac21 and (B) Bac23 and Bac24 at a MOI of 5 for 2 – 5 days.  Lanes 1 labelled 
HaSV signify a sample of wild type HaSV isolated from H. armigera larvae.  The 
lanes labelled AcMNPV signify protein derived from cells infected with the 
baculovirus vector AcMNPV.  The size markers are presented to the left of each 
figure (in kDa) and bands believed to represent p71 (VCap) and p64 (β) by arrows to 
the right.  Anti-VCap antibodies were used at a 1 in 10 000 dilution.   
 
Having optimised VCap expression, it was important to determine whether p17 could 
be detected in the baculovirus infected Sf9 cells under the same conditions.  For this 
reason the same whole cell extracts used above were further analysed for the 
presence of p17 by SDS-PAGE and western blot.  A protein cross-reacting with p17- 
specific antibodies, migrating at approximately 24 kDa, was detected in cell free 
extracts derived from Bac20, Bac23 and Bac24 infected cells (Fig. 3.10, lanes 3, 5 
and 6) but not in Bac21-infected cells (Fig. 3.10, lane 4) or in cells infected with the 
control baculovirus (Fig. 3.10, lane 2).  This protein migrated slightly lower than 
purified, recombinant His-tagged p17 (Fig. 3.10, lanes 1 vs. 3).  The slight difference 
in size is to be expected due to the presence of the 6x His tag adding to the weight 
of the control p17.  
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Figure 3.10: Detection of p17 in baculovirus-infected Sf9 cells.  Whole cell 
extracts were resolved by SDS-PAGE (top) and western analysis (below) with anti-
p17 antibodies used to detect p17 expression.  His-p17: 6x His-tagged p17 
expressed in E. coli BL21 cells and purified by nickel affinity chromatography.  
AcMNPV:  protein derived from cells infected with the baculovirus vector AcMNPV.  
The anti-p17 antibodies were used at a dilution of 1: 25000.  The position of the 
molecular weight marker proteins is indicated on the left of the images.  The position 
of p71 (VCap) and p17 are indicated to the right of the figure. 
 
It was concluded from this data that three of the four recombinant baculoviruses 
were expressing p17.  This represents an important improvement over the plasmid-
based expression system, in which no p17 could be detected in cell free extracts.  In 
addition it is important to note that the p17 ORF has a poor Kozak sequence and that 
despite this, p17 could be detected in baculovirus infected cells via western blot.  
P17 expression was still down-regulated relative to VCap, given that VCap could still 
be detected via Coomassie staining alone and p17 could not. The expression of 
VCap also resulted in a stronger signal from the same samples using western 
analysis (Fig. 3.9, lanes 9 and 10 vs. Fig. 3.10 lanes 3, 5 and 6).  The mutation on 
the start codon of the p17 ORF on Bac21 prevented its expression as predicted from 
its design (Fig. 3.10, lane 4).  Importantly, the ability of Bac21 to express VCap (to 
the same level as the other baculoviruses) was maintained (Fig. 3.9, lane 10).  The 
final conclusion one can make from the data presented, is that Bac23 and Bac24 are 
responsible for slightly higher levels of p17 expression than Bac20.  This is based on 
the fact that the signal from the western blot is stronger in lanes 5 and 6 in Fig. 3.10 
than in lane 2, despite equivalent amounts of protein being loaded (Fig. 3.10, top 
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panel).  This is an interesting observation given that p17 is expressed off the polH 
promoter from Bac23 and Bac24 while it is expressed off p10 in Bac20. 
 
3.5 RNA packaging by bac-VLPs assembled in the presence 
and absence of p17 
A total of 2.8 x107 Sf9 cells (two T75 flasks) were infected with each of the 
baculoviruses Bac20, Bac21, Bac23 and Bac24 at a MOI of 5.  Following 4 days of 
incubation at 28 °C, the cells were subjected to a VLP purification protocol adapted 
from Taylor et al. (2002) and Bothner et al. (2005).  This method employs an acidic 
(pH 5.0) sodium acetate buffer in order to favour the maturation of the VLPs, and 
stabilisation of the particles.  Absorbance readings at 280 nm were used to 
determine the concentration of the VLPs purified and approximately 50 µg was 
purified on average from each preparation.  Fewer VLPs were obtained using the 
plasmid expression system even though double the amount of cells was used (four 
T75 flasks vs. two T75 flasks), making the baculovirus expression system a more 
efficient method for producing VLPs.  SDS-PAGE analysis revealed a small amount 
of p71 with the majority being p64, which co-migrated with wild type HaSV (Fig. 3.11, 
lanes 3 – 6).  The predominance of p64 relative to p71 in all the VLP samples 
confirmed that the majority of the particles were fully matured.     
 
 
 
Figure 3.11:  SDS-PAGE analysis of HaSV VLPs from recombinant baculovirus-
infected cells.  The molecular weight marker is indicated to the left and the 
presence of p64, indicative of mature VLPs and p71 (VCap) to the right. 
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The data presented in section 2 of this chapter suggested that when utilising the 
plasmid expression system for the co-expression of p17 and p71, there was a 
requirement for the expression of p17 for RNA 2 to be packaged effectively into 
VLPs.  The first question that the baculoviruses would aide in answering was 
whether or not the expression of p17 still mediated packaging when the same 
experiment was duplicated using recombinant baculoviruses Bac20 and Bac21 to 
make the VLPs.  Due to the fact that HaSV RNA could be transcribed off a separate 
RNA strand using Bac23 and Bac24, the second question that could be asked was 
whether or not the VLPs were able to package viral RNA that is not RNA 2 (cis vs. 
trans packaging).  Finally, taking into account the answers to these questions, a 
conclusion could be made as to whether RNA 2 packaging into bac-VLPs is specific 
or non-specific and whether or not p17 expression has any effect on this.   
 
In order to answer the questions raised above it was important to confirm that both 
the HaSV RNA 2 and p17 mRNA transcripts were present in baculovirus-infected Sf9 
cells.  Accordingly, total cellular RNA including baculoviral transcripts was extracted 
from Sf9 cells infected with recombinant baculoviruses Bac20, Bac21, Bac23, Bac24 
and VCAP.  The VCAP recombinant baculovirus contains only the p71 ORF with an 
optimised Kozak, and expresses p71 under the control of the polH promoter.  This 
baculovirus is representative of pMV26, a plasmid developed in the Vlok (2009) 
study and mentioned in section 1.  The RNA was resolved by denaturing agarose gel 
electrophoresis and subjected to northern analysis to probe for the presence of 
HaSV RNA 2-derived transcripts. 
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Figure 3.12: Northern analysis of cellular RNA from uninfected and baculovirus 
infected Sf9 cells.  (A) Analysis of total cellular RNAs by denaturing agarose gel 
electrophoresis; (B) Northern analysis probing for the presence of HaSV RNA2.  
Cellular RNA from AcMNPV (lanes 1 and 5), Bac20 (lane 2), Bac21 (lane 3), VCAP 
(lane 4), Bac23 (lane 6) and Bac24 (lane 7) infected cells was used in this 
experiment.  In addition uninfected Sf9 cellular RNA (lane 8) and RNA extracted from 
wild type HaSV (lane 9) was also analysed.  The molecular weight standards are 
indicated to the left of the gel, while the arrows next to each image indicate the 
positions of cellular RNA, wild type (wt) HaSV RNA1 and RNA 2, RNA 2 derived 
from the p10 promoter (RNA 2), un-cleaved RNA 2 derived from the p10 promoter 
(RNA-PolyA) and p17 mRNA derived from the polH promoter. 
       
Ethidium bromide staining of cellular RNAs resolved by denaturing agarose gel 
electrophoresis did not reveal any dominant bands corresponding to the HaSV RNA 
transcripts expressed by the recombinant baculoviruses (Fig. 3.12 A).  However the 
RNA 2-derived transcripts were detected by northern analysis using a probe directed 
against HaSV RNA 2.  Two transcripts of approximately 3600 bases and 2500 
bases, respectively, were detected in Bac20, Bac21, Bac23 and Bac24 infected 
cells, as observed previously using the plasmid derived expression system (Fig. 3.3, 
B lane 5 and Fig. 3.12 B).  The second of the two (labelled RNA 2) migrated to 
approximately the same position as viral RNA 2 (Fig. 3.12 B, lanes 2, 3, 6 and 7 vs. 
9), while the larger fragment was attributed to the uncleaved mRNA.  The mRNA 
transcribed from the VCAP baculovirus migrated at a relative size of approximately 
3000 bases, which is slightly bigger than viral RNA 2 (Fig. 3.12 B, lane 4 vs. 9).  The 
size of this band can be explained by the fact that no ribozyme is present 
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downstream of the VCap ORF on the VCAP baculovirus.  A polyA tail is thus added 
to the p71 ORF making it bigger than RNA 2 but smaller than RNA 2(PolyA).  
Interestingly, there was a stronger signal for the VCap transcript from the same 
relative concentration of total RNA.  This suggested that more VCap RNA is being 
transcribed from this baculovirus, when compared to the recombinant baculoviruses 
developed in this study, probably as a result of the optimised Kozak sequence on the 
p71 ORF. 
 
An approximately 900 base size RNA band was also detected in the Bac23 and 
Bac24-infected cells but absent in Bac20, Bac21 and VCap-infected cells (Fig. 3.14 
B, lanes 6 and 7 vs. lanes 2, 3 and 4).  It was concluded that this band represented 
the p17 mRNA expressed under the control of the polH promoter in Bac23 and 
Bac24.  Taken together, this data confirmed the expression of the full length RNA 2-
derived transcript under the control of the p10 promoter in Bac20, Bac21, Bac23 and 
Bac24 and the p17 mRNA from the polH promoter in Bac23 and Bac24.  
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Figure 3.13: Northern analysis of RNA extracted from bac-VLPs.  (A) Analysis of 
VLP RNAs by denaturing agarose gel electrophoresis and (B) Northern analysis 
probing for the presence of HaSV RNA2.  RNA extracted from VLPs derived from the 
infection of Bac20 (lane 1), Bac21 (lane 2), VCAP (lane 3), Bac23 (lane 4) and 
Bac24 (lane 5) was analysed by denaturing gel electrophoresis and northern 
analysis.  RNA extracted from wild type HaSV (lane 6) was also analysed.  The 
northern blot was also overexposed in order to clarify fainter signals.  The molecular 
weight standards are indicated to the left of the gel, while the arrows next to each 
image indicate the positions of wild type (wt) HaSV RNA1 and RNA 2, RNA 2 
derived from the p10 promoter (RNA 2), un-cleaved RNA 2 derived from the p10 
promoter (RNA-PolyA), p17 mRNA derived from the polH promoter as well as the 
size of RNA molecules of unknown origin. 
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The denaturing gel stained with ethidium bromide revealed three consistently sized 
bands of RNA extracted from VLPs derived from Bac21, Bac23 and Bac24 
infections.  The size of these RNAs is approximately 3070 bases, 1530 bases and 
less than 200 bases respectively.  It was difficult to determine whether the two larger 
RNAs represented viral RNA as neither of the 3070 or 1530 base bands is consistent 
to the size of RNA 2 or the RNA 2(PolyA) species (Fig. 3.13 A, lanes 2, 4 and 5).  
This raised the possibility that each of the bac-VLPs may have packaged random 
cellular RNA.  Not enough RNA was extracted from Bac20-VLPs to be effectively 
defined on the gel (Fig. 3.13 A, lane 1).  Repeated attempts were made to equilibrate 
the amount of RNA analysed so that it was approximately equal for each set of VLPs 
but these were unsuccessful due to the poor integrity of the extracted RNA.  
Therefore, less Bac20 and Bac24-VLP RNA was analysed compared to the other 
VLPs.  Northern analysis using an HaSV RNA 2-specific probe, detected two 
transcripts in each set of VLPs corresponding in size to the RNA 2 and RNA 2 
(PolyA) RNAs detected in the infected cells (Fig. 3.12 B, lanes 2, 3, 6 and 7 vs. Fig. 
3.13 B, lanes 1, 2, 4 and 5).  Both RNA 2 and RNA 2(PolyA) were observed from 
RNA extracted from Bac20 and Bac24 derived VLPs by overexposing the northern 
blot (Fig. 3.13 B right hand blot, lanes 1 and 5).  VLPs isolated from VCAP infected 
cells also packaged the VCap mRNA detected in the cells (Fig. 3.12 B, lane 4 vs. 
Fig. 3.13 B, lane 3).   
 
VLPs purified from cells infected with Bac23 and Bac24 also packaged an additional 
RNA of 900 bases, corresponding in size to the p17-encoding transcript expressed 
by the polH promoter and detected in the Bac23 and Bac24 infected cells (Fig. 3.12 
B, lanes 6 and 7 vs. Fig. 3.13 B, lanes 4 and 5).  This suggested that RNA other than 
the RNA 2 encoding VCap was also packaged by the VLPs.  However, this RNA 
encoded the p17 ORF and potentially a packaging signal, which could promote the 
packaging of p17 mRNA. 
 
By analysing the RNA extracted from the bac-VLPs it was concluded that the 
expression of p17 had no effect on the encapsidation of RNA 2.  Furthermore, the 
bac-VLPs were also able to package HaSV RNA not derived from RNA 2.  Two 
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interpretations could be made from this data: (1) HaSV RNA packaging is specific for 
any HaSV-derived RNA sequence or (2) bac-VLPs package non-specifically any 
RNA that is produced in abundance in the cell (i.e. baculovirus derived RNA).  In 
order to differentiate between specific and non-specific HaSV RNA packaging 
another experiment was devised.  
 
The next set of northern blots aimed at deciphering whether the HaSV VLPs were 
preferentially packaging HaSV RNA transcripts over other baculoviral transcripts, 
and, therefore, specific vs non-specific packaging.  This was done using Bac20 and 
Bac21, which encode the viral RNA 2 transcript in the p10 direction and have no 
HaSV-derived sequence downstream of the polH promoter (Fig. 3.4, A and C).  If 
packaging was non-specific, then one would expect VLPs produced by these two 
baculoviruses to also contain the other, abundant mRNAs, such as that expressed 
by the baculoviral polH promoter.  A polH specific probe was thus designed to detect 
the 91 bases of the polH cloning cassette. 
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Figure 3.14: Detection of small RNAs derived from the expression of the polH 
cloning cassette in cells infected with Bac20, Bac21 and VCAP.  (A) Analysis of 
cellular RNAs by denaturing agarose gel electrophoresis; (B) Northern analysis 
probing for transcripts derived from the empty polH cloning cassette.  In this 
experiment only Bac20 (lane 1), Bac21 (lane 2) and VCAP (lane 3) recombinant 
baculoviruses were analysed alongside uninfected Sf9 cells (lane 4) and wild type 
HaSV RNA (lane 5).  The molecular weight standards are indicated to the left of the 
gel while RNAs derived from the baculoviruses are indicated with arrows to the right. 
 
Northern analysis of total RNA extracted from cells infected with Bac20 and Bac21 
showed the presence of polH-derived transcripts of approximately 480 bases (Fig.  
(Fig. 3.14 B, lanes 1 and 2).  This band was not present in cells infected with the 
VCAP baculovirus or in uninfected cells (Fig. 3.14 B, lanes 3 and 4).  In addition, the 
polH probe detected a second, larger band in Bac20, Bac21 and VCAP-infected cells 
(Fig. 3.14 B, lanes 1, 2 and 3), but not in uninfected cells (Fig. 3.14 B, lane 4).   The 
largest RNA band detected in the Bac20 and Bac21 infected cells was approximately 
the same size as RNA 2 detected by the RNA 2-specific probe in the previous two 
blots (Fig. 3.12 B and Fig. 3.13 B).  Although the polH probe was not designed to 
detect RNA 2, it appeared that due to a small degree of overlap in the sequence of 
the p10 and polH cloning cassettes, the probe was able to bind both baculovirus-
expressed RNAs.  This is supported by the fact that baculoviral VCap mRNA, which 
is fused downstream of the polH promoter, was detected but wild type HaSV RNA 2 
was not (Fig. 3.14 B, lanes 3 vs. 5). 
 
80 
 
 
A 
 
B 
 
     
Figure 3.15: Packaging of non-viral RNA by bac-VLPs.  (A) Denaturing agarose 
gel electrophoresis and (B) Northern blot analysis of RNA extracted from Bac20 
(lane 1), Bac21 (lane 2) and VCAP (lane 3) HaSV VLPs, probed for RNAs containing 
polH non-coding sequence.  RNA extracted from wild type HaSV was also analysed 
(lane 4).  The molecular weight standards are indicated to the left of the gel while 
RNA’s derived from the baculoviruses are indicated with arrows to the right. 
 
The packaged RNA was resolved by denaturing agarose gel electrophoresis and 
visualised by staining with ethidium bromide.  This revealed a similar band pattern of 
packaged RNA as the previous denaturing gel analysis of the VLPs (Fig. 3.13 A vs. 
Fig. 3.15 A).  Two bands originating from the polH cloning cassette of 488 and 208 
bases respectively were observed towards the bottom of the gel (Fig. 3.15 A, lanes 
1, 2 and 3).  Over and above these RNAs, there were less defined RNA species 
larger than 4000 bases that were also resolved on the gel (Fig. 3.15 A, lanes 1, 2 
and 3).  None of these RNAs were present in wild type HaSV particles (Fig. 3.15 A, 
lane 4 vs. 1, 2 and 3).  Less RNA from Bac20-VLPs was analysed when compared 
to the Bac21 and VCAP-VLPs (Fig. 3.15 A, lane 1 vs. 2 and 3). 
   
Northern analysis using the polH probe revealed that, as observed before (Fig. 3.13 
B, lanes 2 and 3), Bac21 and VCAP-VLPs packaged RNA 2 and VCap mRNA (Fig. 
3.15 B, lanes 2 and 3).  However, the signal for RNA from Bac20-VLPs was much 
lower, as was observed previously with the RNA 2 probe (Fig. 3.13 B, lane 1 vs. Fig. 
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3.15 B, lane 1).  The two polH RNAs of 488 and 208 bases were also detected by 
northern analysis as a smear towards the bottom of the blot.  Due to the size of 
these RNAs and the binding to the probe it was concluded that the Bac21-VLPs 
packaged non-coding polH RNA. 
 
The VCAP-VLPs appeared to package predominantly VCap mRNA, although in this 
instance the probe was not able to detect non-coding RNA, proven by the fact that 
only VCap RNA was detected previously in VCAP infected cells (Fig. 3.14 B, lane 3 
and Fig. 3.15 B, lane 3).  Therefore, no additional inferences on VCAP-VLP 
packaging can be made.  Bands corresponding to the polH transcript were not 
detected in Bac20 VLPs, which is likely to be due to the uneven loading of the RNA 
samples.  However, when one compares the strength of the polH signal relative to 
the signal from the RNA 2 band in the Bac21-VLP sample, it is possible that the 
Bac20-VLPs may be packaging significantly less or no polH RNA.  No RNA was 
detected by northern blot even when the membrane was over-exposed (Fig. 3.15 B, 
lane 1 vs. 2). 
 
The results of this experiment are thus inconclusive because not as much packaged 
Bac20 RNA was analysed compared to Bac21 RNA.  It therefore, remains uncertain 
whether bac-VLPs package HaSV RNA specifically or non-specifically the most 
abundant RNA proximal to the assembling particle. 
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Chapter 4 
Discussion 
 
4.1 Introduction 
Tetraviruses provide a unique insight into the assembly and packaging biology 
involved in the production of small insect RNA viruses.  They were the first T=4 
symmetry icosahedral viruses to be discovered and many studies have been 
dedicated to identifying how these particles assemble (Canady et al., 2000 and 
2001; Taylor et al., 2002; Matsui et al., 2009).  A major challenge in doing so is the 
fact that these viruses cannot replicate in tissue cultured cells and thus the assembly 
of structurally indistinguishable, yet non-infectious VLPs has provided a useful 
alternative to a replicating system (Agrawal and Johnson, 1995; Tomasicchio et al., 
2007; Gordon et al., 2001).  The packaging of RNA into a capsid particle is an 
important process during assembly and in many instances the combination of the 
RNA and protein components of a virus need to combine in a specific manner in 
order to produce a viable particle (Schneemann, 2006).  Despite this fact, very few 
studies have focused on the packaging element of tetravirus assembly. 
 
Prior to this study, a plasmid transfection system was developed to study the 
assembly and packaging of HaSV VLPs (Vlok, 2009).  This system was used to 
assemble VLPs in Sf9 cells via the co-expression of the two proteins coded for by 
HaSV RNA 2, p17 and VCap (p71), in different contexts.  The VLPs were then 
purified from the cells and their packaging phenotype determined by the content of 
the RNA within (Vlok, 2009).  This system was advantageous in that it was a 
relatively simple way of testing a variety of elements that were potentially important 
to HaSV VLP packaging and it did not require a large amount of time to carry out 
each experiment.  Data developed in this study aided in the formulation of the 
hypothesis that p17 or a signal present on the first 28 codons of the p17 ORF are 
essential for the specific packaging of HaSV RNA 2 into plasmid-VLPs.  This 
hypothesis was based on the observation that no HaSV RNA 2 was packaged by 
VLPs made from the transfection and expression of a plasmid only coding for VCap 
(pMV26 – Fig. 3.1) whereas RNA 2 was packaged by the VLPs made from a wild 
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type RNA 2 plasmid (pMV18 – Fig. 3.1) as well as plasmids in which the UTRs were 
removed but the p17 ORF maintained (pMV20, 26 and 27 – Fig. 3.1).    
 
However, despite its advantages there were certain drawbacks to the plasmid-based 
system.  Firstly, expression levels were not high enough to detect the expression of 
p17 from the plasmids in the insect cells.  Secondly, the yield of VLPs purified from 
the plasmid-transfected cells was not substantial enough to purify large amounts of 
RNA.  It was for this reason that the recombinant baculovirus expression system was 
developed and one of the major aims of this study was to utilise this new system to 
elucidate the specific events involved in the packaging of RNA by tetravirus particles.  
The reasoning behind this study was to develop recombinant bacoluviruses that 
would essentially express the same RNA 2 sequences as the plasmids used in the 
transfection system.  Another major reason to convert to baculoviruses was that two 
proteins could be efficiently expressed from one recombinant virus.  This afforded 
the opportunity to refine the p17-packaging hypothesis by testing whether or not p17 
could direct the packaging of sequences other than RNA 2 (trans packaging), by 
including the p17 ORF on a different cloning cassette.  This would have been more 
challenging using plasmids. 
 
4.2 Comparison of plasmid and baculovirus-mediated 
expression systems 
The data reported by Marli Vlok, (2009) as well the results of this study (section 3.2), 
indicated that plasmid-transfection was a moderately efficient method of producing 
VLPs.  The low level expression of the plasmids resulted in fewer VLPs and thus 
less RNA to analyse.  Expression of p17 could not be detected in the plasmid-
transfected cells by western analysis and, therefore, it was not possible to confirm 
that p17 was required for RNA 2 packaging.  The baculovirus system developed in 
this study was more efficient in terms of protein expression.  Firstly, half the amount 
of cells (two T75 flasks) produced a two-fold increase in purified VLPs.  Secondly, 
p17 was detected in cells infected with the recombinant baculoviruses, which thus 
84 
 
provided reliable data confirming which VLPs were assembled in the presence or 
absence of the protein.   
 
Over and above improving the expression levels of HaSV proteins, baculoviruses 
have the potential to provide further advantages over plasmids.  By utilising the Bac-
to-Bac system it was demonstrated in this study that it was relatively easy to reliably 
produce two or more sets of proteins from one baculovirus, therefore, cutting out the 
need for sometimes complicated plasmid co-transfections.  This made it possible to 
analyse packaging from another angle, in that it allowed for the analysis of the effect 
of p17 on cis or trans packaging.  HaSV is a bi-partite virus and utilises both RNA 1 
and RNA 2 during its infectious cycle (Hanzlik et al., 1993).  Therefore, by taking 
advantage of the bi-directionality of the baculoviruses, a more comprehensive 
approach to the analysis of packaging could be undertaken by including RNA 1 
opposite RNA 2 on a single baculovirus.  Finally, the large scale production of VLPs 
would be extremely useful, regardless of whether the aim is fundamental research or 
biotechnological application.  In this regard, the infection of colonies of insect larvae 
by the recombinant viruses could provide an effective means of large scale VLP 
production.  This approach has been more widely adopted in asian countries but its 
potential to both efficiently and effectively produce large amounts of recombinant 
protein have been documented elsewhere and thus this remains a somewhat 
interesting avenue for the production of VLPs (Kost et al., 2005). 
 
The disadvantage of using recombinant baculoviruses is the time required to develop 
and optimise a functional system.  Compared to cloning plasmids and then carrying 
out a transfection, the development of baculoviruses can take between 2 to 8 months 
after which there is still the optimisation of protein expression.  Despite this, the 
baculovirus system proved an effective means of study the packaging of HaSV 
VLPs.  This system provided additional insights into the packaging biology of HaSV 
that were not necessarily clear from the plasmid-based system. 
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4.3 The packaging of RNA 2 by HaSV VLPs derived from 
plasmid transfection 
As mentioned above, a previous study using a plasmid-transfection system was able 
to show that either the expression of p17 or a signal sequence between the p17 and 
VCap start codons was responsible for the specific packaging of RNA 2 into HaSV 
VLPs (Vlok, 2009).  Further analysis in this study, using the same system, has 
shown that when two codons of the p17 RNA sequence are mutated so that p17 is 
not translated (AUG AGC to GAU AUC), VLPs fail to effectively package RNA 2 
mRNA when compared to a wild type RNA 2-plasmid control (Fig. 3.3).  This data in 
combination with the Vlok, (2009) study suggested that it is p17 expression that was 
required for RNA 2 packaging, although the presence or absence of p17 in the cells 
transfected with wild type (pMV18) or mutated (pAM10) plasmids could not be 
confirmed.  However, since western analysis of the same sequences expressed by 
recombinant baculoviruses confirmed that the mutation had abolished translation of 
p17, it is likely that the protein was not present in the pAM10-transfected cells.  An 
alternative possibility is that p17 is not required for packaging, but rather that there is 
a packaging signal that includes the six mutated nucleotides in pAM10 and that the 
disruption of these, is in fact the reason for the lack of RNA 2 packaging.    
 
4.4 The packaging of RNA 2 by HaSV VLPs derived from the 
baculovirus expression system 
The shortfalls in terms of protein expression meant that the packaging data 
developed using the plasmid expression system could not conclusively implicate p17 
as a requirement for RNA packaging.  An alternative test of the p17 hypothesis was 
constructed by developing recombinant baculoviruses based on the plasmids used 
by Vlok, (2009).   First, two recombinant baculoviruses, namely Bac20 (analogous to 
pMV18) and Bac21 (analogous to pAM10), were constructed.  These baculoviruses 
were constructed in such a way that the mRNA that resulted from transcription from 
the p10 promoter would be precise at the 3’end (via the HC ribozyme) while 
containing approximately 125 bp of baculoviral RNA at the 5’end.  Short regions of 
non-viral RNA have been reported to effect viral processes such as assembly and 
replication and thus the precise fusion of RNA 2 to the 5’end of the promoter remains 
a goal for future experiments (Kay et al., 2001).  Western analysis confirmed that 
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VLPs derived from Bac20, assembled in the presence of p17 while Bac21-VLPs 
assembled without the protein (Fig. 3.10 and Fig. 3.11).  In terms of the packaging of 
the bac-VLPs, northern blot analysis (Fig. 3.13) showed that the VLPs derived from 
Bac20, Bac21 and VCAP (a baculovirus analogous to pMV26) infections all 
packaged both RNA 2 mRNA (representing baculovirus mRNA cleaved by the 
ribozyme) as well as RNA 2(PolyA) mRNA (resulting from the lack of ribozyme 
activity and the addition of a polyA tail to RNA 2).  It was thus concluded that Bac20 
and Bac21 do not require the expression of p17 or a signal sequence between the 
two start codons to package RNA 2 mRNA.  Thus the data obtained from this set of 
bac-VLPs contradicts the results obtained from the plasmid expression system. 
 
As mentioned previously, an advantage of using baculoviruses is that two sets of 
ORFs can be incorporated into one recombinant virus and that this element would 
allow for the analysis of p17-mediated cis/trans RNA packaging.  In order to achieve 
this, two further recombinant baculoviruses were constructed in this study; Bac23 
(pMV18 plus an additional p17 ORF) and Bac24 (pAM10 plus an additional p17 
ORF).  The question posed by making VLPs from these two baculoviruses was 
whether or not the additional p17 mRNA would be packaged by the VLPs.  The 
presence of p17 as well as the purification of VLPs was confirmed by western 
analysis after the infection of both of these viruses (Fig. 3.10 and Fig. 3.11).  It was 
also confirmed that both sets of VLPs were able to package both sets of RNA 2-
derived RNAs (RNA 2 and RNA 2-PolyA) in a similar manner to Bac20 and Bac21 
(Fig. 3.13).  In addition to the RNA 2 species, Bac23 and Bac24-VLPs also packaged 
the p17 mRNA.  This result as well as the result from the analysis of Bac20 and 
Bac21-VLP packaging indicated that the bac-VLPs were either specifically packaging 
any HaSV-derived RNA sequence or simply packaging any RNA that was in 
abundance in the cell, which would include baculovirus derived HaSV-RNA.  
 
Ethidium bromide staining of purified RNA packaged by the bac-VLPs and resolved 
by denaturing agarose gel electrophoresis showed additional RNAs that were not 
detected by northern analysis using the RNA 2-probe (Fig. 3.13 A and Fig. 3.15 A).  
This was interpreted as evidence of the non-specific nature of bac-VLP packaging 
and thus an experiment was designed to test the specificity of HaSV bac-VLP RNA 
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packaging.  This experiment was based on the assumption that a large degree of 
non-coding RNA, derived from the polH promoter, would be transcribed from Bac20 
and Bac21.  This RNA corresponds to the cloning cassette of the Bac20 and Bac21 
viruses and thus if these VLPs were packaging non-specifically (the most abundant 
RNA) then it was reasoned that this RNA should be present in the particles.  The 
northern analysis indicated that Bac21 packaged a variety of non-HaSV RNAs that 
were detected by the polH probe.  No corresponding signals were detected in RNA 
purified from Bac20 derived VLPs (Fig. 3.15 B) suggesting the exclusion of non-viral 
RNA in the presence of p17.  However, this result could also be due to the uneven 
loading of RNA samples because the amount of RNA from the Bac20-VLPs was less 
than that extracted from the Bac21-VLPs.  Thus the data is inconclusive.  It was very 
tempting to formulate the hypothesis that p17 may still have an effect on packaging 
by excluding non-HaSV RNAs but then RNA 2 should still have been detected on the 
blot.  Therefore, RNA packaging in the baculovirus system appeared to be less 
selective than in the plasmid system but whether or not bac-VLPs package RNA 
non-specifically cannot conclusively be stated. 
 
 
4.5 Bac-VLPs versus plasmid-VLPs, how does HaSV package 
its genome? 
The data in this study presents two very different pictures of HaSV RNA packaging.  
On the one hand it was concluded that p17 is very important in the selective 
packaging of RNA 2 (plasmid system) whereas on the other hand VLP packaging is 
non-selective and p17 plays no role (baculovirus system).  The key difference 
between the data from the two systems is the significantly increased levels of 
transcription by baculoviruses compared to plasmids.  Therefore, VLP assembly can 
be described as taking place in an RNA-limiting environment in the plasmid-
transfected cells versus an RNA-excess environment in the baculovirus-infected 
cells. 
 
The question one is therefore, forced to ask is which system is more representative 
of a wild type HaSV infection?  Meaning essentially which system is better for 
studying packaging?  These questions are difficult to answer because like packaging 
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literature, there are also relatively few studies that have focused on the pathogenicity 
of tetravirus infections.  A quantitative study of the pathogenicity of HaSV was 
carried out by Christian and colleagues in 2001 and this revealed that HaSV varied 
in virulence depending on which larval stage the virus infected.  In some instances 
low-level infection was required for the stunting of early instar larvae whereas in 
other instances higher doses could not effect stunting on more developed larvae 
(Christian et al., 2001).  A more in depth analysis was carried out by Brooks et al. 
(2002) who were able to show that the infection of HaSV to early instar H. armigera 
larvae was initiated at multiple points in the midgut and developed into widespread 
foci of infection that covered virtually all the cells.  Furthermore it was proposed that 
due to the immune response of the insects, which results in sloughing of infected 
cells, the virus relies on the speed of RNA replication and assembly to accumulate 
virions before apoptosis (Brooks et al., 2002).  This data suggests that at least 
initially wild type HaSV infection is like the baculovirus system, in that viral RNA is 
produced in excess and many virions are produced rapidly.  Conversely, it also 
suggests that the infected insects do gain a level of immunity of infection relatively 
quickly and thus the RNA-limiting environment may be more representative of larvae 
infected after early instar development.  Exactly where the Sf9 tissue cultured cells fit 
in, in terms of at what stage of development they are being forced to make HaSV 
VLPs, is unclear.  Therefore, it is unclear whether an RNA-limiting or an RNA-excess 
environment is better suited for studying packaging.   
 
An explanation that takes both data sets into account is that p17 plays an important 
role in promoting the selective packaging of viral RNA when RNA is limiting but plays 
a minor role when RNA is in excess.  Even though this hypothesis takes into account 
both sets of data, it fails to explain the RNA packaging observed by tetraviruses in 
the literature.  In contradiction to the bac-VLP packaging data, a specific replication-
independent RNA packaging system has been implied by two groups prior to this 
study.  Agrawal and Johnson (1995) used baculoviruses to express the NωV VCap 
protein (p70) and inadvertently the NωV equivalent of p17 in Sf9 cells.  It was shown 
via northern blots that the resulting VLPs packaged RNA 2, although the specificity 
of this packaging was implied but not necessarily depicted.  
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Figure 4.1: System for the assembly of HaSV VLPs in plant protoplasts.  
Gordon et al. (2001) used the plasmids depicted in (A) to produce VLPs in plant 
protoplasts that would eventually be fed to live larvae.  pR1 and pR2 contain HaSV 
RNA 1 and RNA 2 cDNA while pCAP contains only the VCap ORF.  The HaSV 
genes were inserted into plasmids containing the Cauliflower mosaic virus (CaMV) 
35S promoter (35S-Pro) and poly-adenylation signal (pA) as well as a cis-acting 
ribozyme sequence (depicted by scissors).  Depicted below the plasmids are the two 
sets of VLPs that were hypothesised to be constructed from the transfection of all 
three plasmids (I) or just pR1 and pCAP (II).  (B) Gordon and Waterhouse, (2006) 
reported the results of unpublished data in which pR2 was modified to include a p71-
GFP fusion ORF (pR2-GFP).  Also reported was the analysis the anterior midgut 
regions of larvae infected with the VLP depicted in (B) by fluorescence microscopy 
(figure reproduced from Gordon and Waterhouse, 2006).  
 
In a different study on HaSV (cited in Gordon and Waterhouse, 2005), a plasmid-
based system was developed in which plant protoplasts were transfected with 
constructs containing either HaSV RNA 1, RNA 2 or VCap cDNA (Fig. 4.1 A).  The 
transfected-protoplasts were then fed to healthy H. armigera larvae and the 
assembly of infectious particles was confirmed by electron microscopy and 
bioassays.  Despite the lack of replication in the protoplasts and the lack of any 
northern analysis of RNA extracted from the VLPs purified from the protoplasts, it 
was implied that the VLPs specifically packaged RNA 1, RNA 2 and the VCap 
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mRNAs because the insects showed symptoms of stunting.  The same system was 
modified to introduce a p71-green fluorescence protein (GFP) fusion into the 
protoplasts (Fig. 4.1 B).  The fusion plasmid was introduced together with the VCap 
and RNA 1 plasmids into the protoplasts and when fed to larvae resulted in 
fluorescence when the anterior midgut of the larvae was analysed (Gordon and 
Waterhouse, 2006).    
 
Neither of the two studies set out with the aim of studying HaSV RNA packaging and 
thus the results were not necessarily conclusive.  Despite reporting the packaging of 
RNA 2 in NωV VLPs, Agrawal and Johnson (1995) provided no additional data on 
the packaging of the VLPs or why the VLPs would package only RNA 2, when NωV 
is also a bipartite virus.  In terms of the HaSV VLPs assembled in the protoplasts, no 
data has been provided similar to this study, in which the resulting VLPs were 
analysed by denaturing agarose gel electrophoresis and northern analysis.  This 
therefore, begs the question as to whether or not the plasmids themselves were the 
infecting agent from the protoplasts or the VLPs.   
 
The literature mentioned above as well as both systems described in this study all 
have one fundamental flaw when it comes to analysing the events involved in 
tetraviral RNA packaging.  Using both plasmids and baculoviruses, the proteins 
coded for by RNA 2 have been expressed predominantly in isolation in Sf9 cells.  Yet 
this is not in keeping with the natural infectious cycle of an omegatetravirus which 
requires the translation of RNA 1 and RNA 2 and consequentially replication, 
assembly and then packaging to be infectious.  The problem faced by using these 
systems is that they are artificial assembly systems where not all the natural 
components are available. 
 
The next question is thus, what effect does this have on the analysis of tetraviral 
packaging?  The literature indicates that RNA plays an essential role in the assembly 
of tetraviruses and other structurally similar viruses (Fox et al., 1994).  In broad 
terms, the model for assembly of these viruses relies on RNA binding to capsid 
oligomers early on in assembly and in some cases acting as part of a molecular 
switch (nodaviruses, bromoviruses and PrV) while in other cases it does the 
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fundamental job of neutralising positively charged capsid protein terminals so that 
they can fuse together to form a cohesive particle (Fisher and Johnson, 1993; Speir 
et al., 2010).  Thus if RNA is in fact required for assembly, then one can logically 
assume that RNA will be packaged in any system producing VLPs.  An artificial 
assembly system may force the VLPs to package RNAs in order to assemble a 
particle even if it would not normally do so, essentially requiring a head-full of RNA 
for assembly.   
 
Support for this theory is present in the packaging data provided in this as well as the 
plasmid-based study (Vlok, 2009).  Both studies illustrate that when HaSV RNA 2 is 
packaged, it is accompanied by a larger RNA 2 derived strand (RNA 2-polyA).  In 
both sets of studies the relative abundance of RNA 2 to RNA 2(PolyA) in the VLPs 
has been shown to be approximately equivalent (if not favoured slightly towards RNA 
2-polyA).  This packaging pattern thus looks similar to that of the wild type particles 
where RNA 2 is consistently packaged and RNA 2(PolyA) takes up the space 
normally left for RNA 1 in the VLPs.  Therefore, by assembling the VLPs in an 
artificial system they are forced to package mRNA 2 with the polyA extension.  It 
would be interesting to test whether or not this is the reason why the ribozyme is so 
inefficient.  This also may provide the reason why extraneous RNA is observed by 
denaturing gel analysis of bac-VLP packaging.  In order to create a head-full of RNA, 
the VLPs would potentially be forced to fill the space not taken by the two RNA 2 
species and thus extraneous RNA would be packaged.  Overall this suggests that a 
major challenge in interpreting any data on tetraviral RNA packaging is how to align 
an artificial assembly system with what may occur naturally. 
 
The assembly and packaging of nodaviruses has been studied in a baculovirus 
system that mimics closely the natural conditions of viral infection.  When nodaviral 
RNA 1 and RNA 2 were expressed off baculoviruses, both sets of RNAs were 
replicated and the particles packaged both RNAs to near wild type specificity 
(Krishna, Marshall and Schneemann, 2003).  A very different picture of packaging 
was depicted when only the RNA 2 baculovirus was used (Schneemann et al., 1994; 
Dong et al., 1998).  Subsequent studies employing the replicating system showed 
that nodaviruses utilise trafficking of the assembling virion to replication 
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microdomains as a means of ensuring packaging specificity (Venter et al., 2005 and 
2009).  This illustrates another problem with the artificial system employed in this 
study.  Tetraviruses are structurally related to nodaviruses and may share the 
requirement of replication to ensure effective packaging and thus without replication 
in the baculovirus or plasmid systems, the VLPs may be packaging whatever RNA 
may happen to be proximal to the assembling particle.  Using fluorescence 
microscopy, Short et al. (2010) proposed that endosomes created from membranes 
of the endocytic pathway may represent the site of tetravirus replication.  It will be 
very interesting to see whether or not bac-VLPs or plasmid-VLPs assemble near 
these endosomes regardless of their state of replication.  This would provide a handy 
clue as to whether or not nodaviral and tetraviral packaging is similar.    
 
Fortunately, there is the potential to move away from artificial tetravirus assembly.  
As has been alluded to already, there is evidence that the baculoviruses produced in 
this study can express a different set of proteins from each of the two promoters (p10 
and polH).  The next step in the research project will thus be to introduce RNA 1 into 
the polH cloning cassette of Bac20 and Bac21, effectively introducing all the 
components of HaSV cDNA into a single cell.  This would allow us to ask some 
interesting questions; 1) will both RNA 1 and RNA 2 be able to replicate and what 
effect will the lack of p17 have on this; 2)  will assembly take place and 3) if 
VLPs/viable HaSV particles form what effect will p17 have on packaging.   
 
4.6 Alternative hypotheses for HaSV packaging 
The literature review introduced two structurally similar insect virus families (the 
bromoviruses and nodaviruses) in which there is more information regarding RNA 
packaging.  Although the conclusions can only remain speculative until correctly 
tested, it may be useful to contrast bromovirus and nodavirus packaging 
mechanisms with what is known about tetraviruses.   
 
It has been hypothesised that bromoviruses utilise a “C1-model” of RNA packaging 
in which the concentration of VCap upon initial infection is utilised to allow the protein 
to bind only high affinity RNA binding sites on the viral RNA.  VCap thus acts as a 
“structural identifier” for the RNA 1 molecule and as the VCap concentration 
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increases more copies bind to the ribonucleoprotein complex forming a capsid 
particle (Johnson et al., 2003).  It is tempting to hypothesise that p17 may be some 
sort of “structural identifier”.  Perhaps in an RNA-limiting environment (plasmid-
system) the concentrations of RNA, VCap and p17 are balanced so that p17 is able 
to identify RNA 2 effectively, whereas in an RNA-excess environment (baculovirus-
system) VCap and RNA are able find each other more easily and thus there is no 
need for p17.  Furthermore, the “C1 model” predicted that other sets of RNA could 
also be packaged but that given its identification by VCap, viral RNA is favoured.  
The results of this study indicate that HaSV VLPs have the ability to do the same, as 
RNA derived from polH was packaged by Bac21-derived VLPs but so was RNA 2 
(Fig. 3.15).  Choi and Rao (2003) speculated that BMV utilises both nucleating 
signals which are hypothesised to be 3’ tRNA-like structures as well as packaging 
elements specific to each RNA to ensure VCap binding.  Interestingly, tetraviruses 
also have 3’ tRNA-like structures and this presents one further line of speculative 
evidence towards a bromovirus-like model of packaging.  
 
Nodaviruses utilise an entirely different mechanism of packaging and one that is 
dependent on a variety of interlinked processes in order to function.  It is 
hypothesised that nodaviruses are able to package two sets of RNAs by ensuring 
that the initial ribonucleoprotein complex is shipped to the site of replication where 
the other copy of RNA will be present (Venter et al., 2009).  Therefore, by ensuring 
that all the components of a nodavirus are present in close vicinity, the natural 
affinity of VCap to combine RNA and protein to create a capsid is used to form a 
nodavirus particle.  It is difficult to provide any evidence for a similar process in 
tetraviruses, given that no one has yet been able to set up a replicating system.  
Although given the large degree of structural similarity between the two families it 
may not be very surprising if their packaging mechanisms turn out to be similar. 
 
4.7 Future prospects 
The development of a replicating system for tetraviruses remains the ultimate goal 
as this will provide the means to improve on a variety of aspects of tetravirus 
research.  It is believed that this may be possible utilising the baculovirus mediated 
system.  Over and above setting up a replicating system, our laboratory has begun 
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to develop a direct quantitative PCR (qPCR) system to provide a quantitative figure 
behind the amount of each RNA species being packaged by the particles.  This 
could provide an indication as to the efficiency of RNA 2 packaging by each set of 
bac-VLPs.  In addition, it is believed that novel approaches such as deep sequencing 
of a population of VLPs may be very useful in providing data as to exactly what is 
being packaged by the particles.  By comparing the homo or heterogeneity of the 
RNAs packaged by each set of VLPs to that of wild type packaging one could get a 
very good idea if what is being observed represents a natural packaging 
phenomenon.   
 
Despite the fact that there is now little novelty in the T=4 structure of a tetravirus 
particle, there remains many reasons to still conduct tetravirus research.  Firstly, it 
has been shown in this study that tetraviral RNA packaging may be unique and this 
information can only serve to add to the volume of the relatively small size of RNA 
packaging literature.  Besides the fundamental question of RNA packaging, there is 
also the potential for viruses such as tetraviruses to be small molecule delivery 
vehicles.  It is thus hoped that tetraviruses will one day, not only be relatively 
interesting viruses to study but also a clinically important element of the future. 
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Appendices 
 
Appendix 1 – Primers  
 
Table A1.1: List of Primers used in this study 
Primer Location Direct/ complimentary Sequence (5’- 3’) 
AM7F Nt 1198 – 1223 
of hr:AcMNPV 
promoter 
D AACAACCAAGCTTAATCGAATTCC
G 
AM8R Nt 766 - 738 
p17 - RNA 2 
C AGATCTCTCTTATCTCTGCGTCGA
CGGA 
AM9 
SDM 
Nt 262 – 307 
RNA 2 
D CAGCGTTGATAGCGCCGATTGAT
ATCGAGCACACCATCGCCCAC 
AM10 
SDM 
Nt 307 - 262 
RNA 2 
C GTGGGCGATGGTGTGCTCGATAT
CAAATCCGCGCTATCAACGCTG 
AM13F Nt 283 – 304 
p17 RNA 2 
D AGATCTATGAGCGAGCACACCAT
CGCC 
AM14R Nt 757 - 733 
p17 pMV18 
C CTGCAGTTATCTCTGCGTCGACG
GAGAACT 
M13F AcMNPV bacmid D CCCAGTCACGACGTTGTAAAACG 
M13R AcMNPV bacmid C AGCGGATAACAATTTCACACAGG 
60F Nt 2075 - 2094 
p71 – RNA 2 
D CCCCGCCACTGACAACTTC 
 
AM18 
polH 
Nt 103 – 125 
polH  promoter 
AcMNPV bacmid 
D ATTCATACCGTCCCACCATCGGG 
JRS56 Nt 144 – 164 
5’UTR – RNA 2 
D GTCGTTGGGAGTTTCGTCCG 
JRS57 Nt 862 – 841 
p71 – RNA 2 
C CGGTTCTGAACATCGGAAAGG 
JRS61 Nt 115 – 87   
polH cloning 
cassette 
AcMNPV bacmid 
C CTCTAGTACTTCTCGACAAGCTTG
TCGAG 
Nt - nucleotide 
 
 
 
 
 
96 
 
Appendix 2 – Thermal cycling parameters used in this study  
 
Table A2.1: The cycling parameters for PCR amplification of p17 prior to SDM 
(AM7F to AM8R). 
Stage Temperature (°C) Time No. of cycles 
1 94 2min 1 
2 94 15sec 25 
53 30sec  
72 50sec – 1min  
3 72 7min 1 
4 4 ɷ 
 
Table A2.2: The cycling parameters used for SDM 
Stage Temperature (°C) Time No. of cycles 
1 95 30sec 1 
2 95 30sec 18 
55 1min  
78 4min  
3 4 ɷ 
 
Table A2.3: The cycling parameters used for the analysis of the recombinant 
bacmids 
Stage Temperature (°C) Time No. of cycles 
1 95 2min 1 
2 95 30sec 25 
55 30sec  
78 4min  
3 72 10min 1 
4 4 ɷ 
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Table A2.4: The cycling parameters used for the amplification of the polH 
sequence for the development of an RNA probe 
Stage Temperature (°C) Time No. of cycles 
1 94 2min 1 
2 94 15sec 20 
57 30sec  
72 30sec  
3 72 2min 1 
4 4 ɷ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98 
 
pMV18
7404 bp
p71
p17
HaSV RNA2
HC Ribozyme
Amp R
Kan/Neo R
hr:AcMNPV promoter
SV40 Ori
Nsi I (485 5)
EcoRV (1366)
Sma I (1123)
Sma I (2227)Sma I (505 6)
pAM10
7379 bp
p71
Mutated AUG-EcoRV
HC Ribozyme
Mutated HaSV RNA2
Kan/Neo R
Amp R
hr:AcMNPV promoter
SV40 Ori
Nsi I (4830)
EcoRV (1366)
EcoRV (25 19)
Sma I (1123)
Sma I (2227)Sma I (5031)
pFastBac Dual
5238 bp
p10
Polh F1Intergenic region
Tn7R
Tn7L
SV40 PolyA
HSV tk PolyA Ampr
Gmr
Nsi I (4292)
Sma I (4322)
pAM20
7832 bp
Polh
p10
p17
p71
HSV tk PolyA
SV40 PolyA
Tn7L
Tn7R
F1Intergenic region
HC Ribozyme
HaSV RNA2
Ampr
Gmr
EcoRV (2899)
Nsi I (4265)
Sma I (6889)
EcoRI (6262)
EcoRI (7 196)
pAM21
7832 bp
Polh
p10
p71
HSV tk PolyA
SV40 PolyA
Tn7L
Tn7R
F1Intergenic region
Mutated HaSV RNA2
HC Ribozyme
Mutated AUG-EcoRV
Ampr
Gmr
Nsi I (4292)
Sma I (6916)
EcoRI (6289)
EcoRI (7 223)
EcoRV (2926)
EcoRV (65 99)
Appendix 3 – Plasmid construction  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.1: Construction of pAM20 and pAM21 transfer vectors.  AmpR – 
ampicillin resistance gene; Kan/NeoR – kanamycin/neomycin resistance gene; Gmr 
– gentamycin resistance gene; hrAcMNPV - hybrid promoter from the Autographa 
californica nuclear polyhedrosis virus; SV40 ori – Simian virus 40 origin of 
replication; SV40 polyA - Simian virus 40 polyadenylation signal; p17 – HaSV p17; 
p71 – HaSV VCap/p71; Tn7L and Tn7R – transposon sites.   
 
Ligation into 
pFastBac Dual 
backbone 
Digestion and purification 
of SmaI to NsiI fragments 
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pAM12
3505 bp
p17
F1 ORI
Am pR
pucF prim er
pucR prim er
Bgl II (543)
Pst I (67)
Pst I (576)
pAM20
7 832 bp
Polh
p10
p17
p71
HSV tk PolyA
SV40 PolyA
Tn7L
Tn7R
F1Intergenic region
HC Ribozyme
HaSV RNA2
Gmr
Ampr
Nsi I (4265)
Sma I (6889)
pAM23
8232 bp
p71
p17
p17
p10
Polh
HaSV RNA2
HC Ribozyme
F1Intergenic region
Tn7R
Tn7L
SV40 PolyA
HSV tk PolyA
Ampr
Gmr
Nsi I (4265)
Sma I (6889)
pAM22
5638 bp
Polh
p10
p17
HSV tk PolyA
SV40 PolyA
Tn7L
Tn7R
F1Intergenic region
Gmr
Ampr
Nsi I (4840)
Pst I (1)
Sma I (487 0)
pFastBac Dual
5238 bp
p10
Polh
F1Intergenic region
Tn7R
Tn7L
SV40 PolyA
HSV tk PolyA Ampr
Gmr
BamH I (4607)
Pst I (4691)
 
 
 
 
 
 
 
 
 
 
 
 
        
    
 
 
 
 
 
 
 
 
 
Figure A3.2: Construction of pAM23.  The construction of pAM24 followed the 
same protocol except pAM21 was used instead of pAM20 to yield pAM24.  AmpR – 
ampicillin resistance gene; Kan/NeoR – kanamycin/neomycin resistance gene; Gmr 
– gentamycin resistance gene; hrAcMNPV - hybrid promoter from the Autographa 
californica nuclear polyhedrosis virus; SV40 ori – Simian virus 40 origin of 
replication; SV40 polyA - Simian virus 40 polyadenylation signal; p17 – HaSV p17; 
p71 – HaSV VCap/p71; Tn7L and Tn7R – transposon sites. 
 
Digestion and 
purification of SmaI to 
NsiI fragment 
Digestion and 
purification of BamHI 
to PstI backbone 
Digestion and 
purification of PstI 
to BglII fragment 
Ligation 
Digestion and purification of 
NsiI to BamHI backbone 
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